{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:52:25Z","timestamp":1787237545888,"version":"build-2736575974"},"reference-count":226,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12223-025-01388-9","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T04:11:39Z","timestamp":1765339899000},"page":"235-265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Epstein-Barr virus and human MiRNAs crosstalk: orchestrating latency, lytic cycle, and immune system modulation"],"prefix":"10.1007","volume":"71","author":[{"given":"Reda M.","family":"Mansour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5410-7936","authenticated-orcid":false,"given":"Gharieb S.","family":"El-Sayyad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hemdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal I.","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif S.","family":"Abdel Mageed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Mahdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Abuelhaded","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimaa A.","family":"Farag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem K.","family":"Shahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara A.","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed M.","family":"El-Shora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rokia","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0136-7096","authenticated-orcid":false,"given":"Ahmed S.","family":"Doghish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"1388_CR1","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.3390\/ijms22062927","volume":"22","author":"A Afrasiabi","year":"2021","unstructured":"Afrasiabi A, Fewings NL, Schibeci SD, Keane JT, Booth DR, Parnell GP, Swaminathan S (2021) The interaction of human and epstein\u2013barr virus Mirnas with multiple sclerosis risk loci. Int J Mol Sci 22:2927. https:\/\/doi.org\/10.3390\/ijms22062927","journal-title":"Int J Mol Sci"},{"key":"1388_CR2","doi-asserted-by":"publisher","first-page":"E6467","DOI":"10.1073\/pnas.1605884113","volume":"113","author":"M Albanese","year":"2016","unstructured":"Albanese M, Tagawa T, Bouvet M, Maliqi L, Lutter D, Hoser J, Hastreiter M, Hayes M, Sugden B, Martin L, Moosmann A, Hammerschmidt W (2016) Epstein-Barr virus Micrornas reduce immune surveillance by virus-specific CD8\u2009+\u2009T cells. Proc Natl Acad Sci USA 113:E6467-e6475. https:\/\/doi.org\/10.1073\/pnas.1605884113","journal-title":"Proc Natl Acad Sci USA"},{"key":"1388_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/jvi.01667-16","volume":"91","author":"M Albanese","year":"2017","unstructured":"Albanese M, Tagawa T, Buschle A, Hammerschmidt W (2017) Micrornas of Epstein-Barr virus control innate and adaptive antiviral immunity. J Virol 91:10\u20131128. https:\/\/doi.org\/10.1128\/jvi.01667-16","journal-title":"J Virol"},{"key":"1388_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.14740\/ijcp525","volume":"13","author":"SH Alsheikh","year":"2024","unstructured":"Alsheikh SH, Alsheikh N, AlSaleh M (2024) X-linked lymphoproliferative disease type 2 with activation of hemophagocytic lymphohistiocytosis secondary to Epstein-Barr virus infection. Int J Clin Pediatr 13:26\u201333. https:\/\/doi.org\/10.14740\/ijcp525","journal-title":"Int J Clin Pediatr"},{"issue":"1","key":"1388_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/1750-9378-9-12","volume":"9","author":"MR Ambrosio","year":"2014","unstructured":"Ambrosio MR, Navari M, Di Lisio L, Leon EA, Onnis A, Gazaneo S, Mundo L, Ulivieri C, Gomez G, Lazzi S (2014) The Epstein Barr-encoded BART-6-3p microrna affects regulation of cell growth and immuno response in Burkitt lymphoma. Infect Agent Cancer 9(1):12. https:\/\/doi.org\/10.1186\/1750-9378-9-12","journal-title":"Infect Agent Cancer"},{"key":"1388_CR6","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1128\/jvi.01528-10","volume":"85","author":"R Amoroso","year":"2011","unstructured":"Amoroso R, Fitzsimmons L, Thomas WA, Kelly GL, Rowe M, Bell AI (2011) Quantitative studies of Epstein-Barr virus-encoded Micrornas provide novel insights into their regulation. J Virol 85:996\u20131010. https:\/\/doi.org\/10.1128\/jvi.01528-10","journal-title":"J Virol"},{"key":"1388_CR7","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41375-018-0178-x","volume":"33","author":"E Anastasiadou","year":"2019","unstructured":"Anastasiadou E, Stroopinsky D, Alimperti S, Jiao AL, Pyzer AR, Cippitelli C, Pepe G, Severa M, Rosenblatt J, Etna MP (2019) Epstein\u2009\u2013\u2009Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas. Leukemia 33:132\u2013147. https:\/\/doi.org\/10.1038\/s41375-018-0178-x","journal-title":"Leukemia"},{"key":"1388_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2023.101116","volume":"31","author":"M Andelic","year":"2023","unstructured":"Andelic M, Marchi M, Marcuzzo S, Lombardi R, Faber CG, Lauria G, Salvi E (2023) Archival skin biopsy specimens as a tool for miRNA-based diagnosis: technical and post-analytical considerations. Molecular Therapy Methods & Clinical Development 31:101116. https:\/\/doi.org\/10.1016\/j.omtm.2023.101116","journal-title":"Molecular Therapy Methods & Clinical Development"},{"key":"1388_CR9","doi-asserted-by":"publisher","first-page":"12825","DOI":"10.1128\/jvi.02139-14","volume":"88","author":"V Aubry","year":"2014","unstructured":"Aubry V, Mure F, Mariam\u00e9 B, Deschamps T, Wyrwicz LS, Manet E, Gruffat H (2014) Epstein-Barr virus late gene transcription depends on the assembly of a virus-specific preinitiation complex. J Virol 88:12825\u201312838. https:\/\/doi.org\/10.1128\/jvi.02139-14","journal-title":"J Virol"},{"key":"1388_CR10","doi-asserted-by":"publisher","first-page":"1557483","DOI":"10.3389\/fimmu.2025.1557483","volume":"16","author":"C Ballerini","year":"2025","unstructured":"Ballerini C, Amoriello R, Maghrebi O, Bellucci G, Addazio I, Betti M, Aprea MG, Masciulli C, Caporali A, Penati V, Ballerini C, De Meo E, Portaccio E, Salvetti M, Amato MP (2025) Exploring the role of EBV in multiple sclerosis pathogenesis through EBV interactome. Front Immunol 16:1557483. https:\/\/doi.org\/10.3389\/fimmu.2025.1557483","journal-title":"Front Immunol"},{"key":"1388_CR11","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/nar\/gkm1080","volume":"36","author":"S Barth","year":"2008","unstructured":"Barth S, Pfuhl T, Mamiani A, Ehses C, Roemer K, Kremmer E, J\u00e4ker C, H\u00f6ck J, Meister G, Gr\u00e4sser F (2008) Epstein\u2013Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res 36:666\u2013675. https:\/\/doi.org\/10.1093\/nar\/gkm1080","journal-title":"Nucleic Acids Res"},{"key":"1388_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.15406\/jhvrv.2021.09.00237","volume":"9","author":"I Bastawecy","year":"2021","unstructured":"Bastawecy I (2021) Mode of infection and some diseases caused by Epstein Barr virus: the most ubiquitous, common malignant and characteristic virus. J Hum Virol Retrovirol 9:6\u20139. https:\/\/doi.org\/10.15406\/jhvrv.2021.09.00237","journal-title":"J Hum Virol Retrovirol"},{"key":"1388_CR13","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/sj.cdd.4402055","volume":"14","author":"G Bellot","year":"2007","unstructured":"Bellot G, Cartron PF, Er E, Oliver L, Juin P, Armstrong LC, Bornstein P, Mihara K, Manon S, Vallette FM (2007) TOM22, a core component of the mitochondria outer membrane protein translocation pore, is a mitochondrial receptor for the proapoptotic protein Bax. Cell Death Differ 14:785\u2013794. https:\/\/doi.org\/10.1038\/sj.cdd.4402055","journal-title":"Cell Death Differ"},{"key":"1388_CR14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s12033-016-9951-0","volume":"58","author":"M Bergallo","year":"2016","unstructured":"Bergallo M, Merlino C, Montin D, Galliano I, Gambarino S, Mareschi K, Fagioli F, Montanari P, Martino S, Tovo P-A (2016) Development of a low-cost stem-loop real-time quantification PCR technique for EBV miRNA expression analysis. Mol Biotechnol 58:540\u2013550. https:\/\/doi.org\/10.1007\/s12033-016-9951-0","journal-title":"Mol Biotechnol"},{"key":"1388_CR15","doi-asserted-by":"publisher","first-page":"e1001114","DOI":"10.1371\/journal.ppat.1001114","volume":"6","author":"M Bergbauer","year":"2010","unstructured":"Bergbauer M, Kalla M, Schmeinck A, G\u00f6bel C, Rothbauer U, Eck S, Benet-Pag\u00e8s A, Strom TM, Hammerschmidt W (2010) CpG-methylation regulates a class of Epstein-Barr virus promoters. PLoS Pathog 6:e1001114. https:\/\/doi.org\/10.1371\/journal.ppat.1001114","journal-title":"PLoS Pathog"},{"key":"1388_CR16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/1479-5876-11-280","volume":"11","author":"B Bilir","year":"2013","unstructured":"Bilir B, Kucuk O, Moreno CS (2013) Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells. J Transl Med 11:280. https:\/\/doi.org\/10.1186\/1479-5876-11-280","journal-title":"J Transl Med"},{"key":"1388_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116066","volume":"25","author":"M Billi","year":"2024","unstructured":"Billi M, De Marinis E, Gentile M, Nervi C, Grignani F (2024) Nuclear miRNAs: gene regulation activities. Int J Mol Sci 25:6066. https:\/\/doi.org\/10.3390\/ijms25116066","journal-title":"Int J Mol Sci"},{"key":"1388_CR18","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S1286-4579(02)01605-2","volume":"4","author":"GA Bishop","year":"2002","unstructured":"Bishop GA, Busch LK (2002) Molecular mechanisms of B-lymphocyte transformation by Epstein\u2013Barr virus. Microbes Infect 4:853\u2013857. https:\/\/doi.org\/10.1016\/S1286-4579(02)01605-2","journal-title":"Microbes Infect"},{"key":"1388_CR19","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/clinchem\/hvaf043","volume":"71","author":"SA Bustin","year":"2025","unstructured":"Bustin SA, Ruijter JM, van den Hoff MJB, Kubista M, Pfaffl MW, Shipley GL, Tran N, R\u00f6diger S, Untergasser A, Mueller R, Nolan T, Milavec M, Burns MJ, Huggett JF, Vandesompele J, Wittwer CT (2025) MIQE 2.0: revision of the minimum information for publication of quantitative real-time PCR experiments guidelines. Clin Chem 71:634\u2013651. https:\/\/doi.org\/10.1093\/clinchem\/hvaf043","journal-title":"Clin Chem"},{"key":"1388_CR20","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1371\/journal.ppat.0020023","volume":"2","author":"X Cai","year":"2006","unstructured":"Cai X, Sch\u00e4fer A, Lu S, Bilello JP, Desrosiers RC, Edwards R, Raab-Traub N, Cullen BR (2006) Epstein\u2013Barr virus MicroRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2:e23. https:\/\/doi.org\/10.1371\/journal.ppat.0020023","journal-title":"PLoS Pathog"},{"key":"1388_CR21","doi-asserted-by":"publisher","first-page":"7838","DOI":"10.18632\/oncotarget.3046","volume":"6","author":"L Cai","year":"2015","unstructured":"Cai L, Li J, Zhang X, Lu Y, Wang J, Lyu X, Chen Y, Liu J, Cai H, Wang Y, Li X (2015a) Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma. Oncotarget 6:7838\u20137850. https:\/\/doi.org\/10.18632\/oncotarget.3046","journal-title":"Oncotarget"},{"key":"1388_CR22","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1038\/onc.2014.341","volume":"34","author":"L Cai","year":"2015","unstructured":"Cai L, Lyu X, Luo W, Cui X, Ye Y, Yuan C, Peng Q, Wu D, Liu T, Wang E (2015b) EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN. Oncogene 34:2156\u20132166. https:\/\/doi.org\/10.1038\/onc.2014.341","journal-title":"Oncogene"},{"key":"1388_CR23","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1128\/jvi.02136-07","volume":"82","author":"JE Cameron","year":"2008","unstructured":"Cameron JE, Yin Q, Fewell C, Lacey M, McBride J, Wang X, Lin Z, Schaefer BC, Flemington EK (2008) Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J Virol 82:1946\u20131958. https:\/\/doi.org\/10.1128\/jvi.02136-07","journal-title":"J Virol"},{"key":"1388_CR24","first-page":"3201","volume":"32","author":"JY-W Chan","year":"2012","unstructured":"Chan JY-W, Gao W, Ho W-K, Wei WI, Wong T-S (2012) Overexpression of Epstein-Barr virus-encoded microRNA-BART7 in undifferentiated nasopharyngeal carcinoma. Anticancer Res 32:3201\u20133210","journal-title":"Anticancer Res"},{"key":"1388_CR25","doi-asserted-by":"publisher","first-page":"e12745","DOI":"10.1371\/journal.pone.0012745","volume":"5","author":"S-J Chen","year":"2010","unstructured":"Chen S-J, Chen G-H, Chen Y-H, Liu C-Y, Chang K-P, Chang Y-S, Chen H-C (2010) Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. PLoS One 5:e12745. https:\/\/doi.org\/10.1371\/journal.pone.0012745","journal-title":"PLoS One"},{"key":"1388_CR26","doi-asserted-by":"publisher","first-page":"e1007535","DOI":"10.1371\/journal.ppat.1007535","volume":"15","author":"Y Chen","year":"2019","unstructured":"Chen Y, Fachko D, Ivanov NS, Skinner CM, Skalsky RL (2019) Epstein-Barr virus MicroRNAs regulate B cell receptor signal transduction and lytic reactivation. PLoS Pathog 15:e1007535","journal-title":"PLoS Pathog"},{"key":"1388_CR27","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1038\/s41388-024-03061-w","volume":"43","author":"Y Chen","year":"2024","unstructured":"Chen Y, Di M, Tang Y, Zhao J, Wang Q, Guo Z, Li Y, Ouyang D, Yang J, Chen H (2024) Epstein-Barr virus causes vascular abnormalities in epithelial malignancies through upregulating ANXA3-HIF-1\u03b1-VEGF pathway. Oncogene 43:2143\u20132159. https:\/\/doi.org\/10.1038\/s41388-024-03061-w","journal-title":"Oncogene"},{"key":"1388_CR28","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.medj.2022.02.005","volume":"3","author":"T Chitnis","year":"2022","unstructured":"Chitnis T, Weiner HL (2022) Targeting Epstein-Barr virus to treat MS. Med 3:159\u2013161. https:\/\/doi.org\/10.1016\/j.medj.2022.02.005","journal-title":"Med"},{"key":"1388_CR29","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.chom.2013.11.009","volume":"14","author":"Y-F Chiu","year":"2013","unstructured":"Chiu Y-F, Sugden AU, Sugden B (2013) Epstein-Barr viral productive amplification reprograms nuclear architecture, DNA replication, and histone deposition. Cell Host Microbe 14:607\u2013618","journal-title":"Cell Host Microbe"},{"key":"1388_CR30","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.mcn.2015.07.004","volume":"68","author":"KJ Cho","year":"2015","unstructured":"Cho KJ, Song J, Oh Y, Lee JE (2015a) MicroRNA-Let-7a regulates the function of microglia in inflammation. Mol Cell Neurosci 68:167\u2013176. https:\/\/doi.org\/10.1016\/j.mcn.2015.07.004","journal-title":"Mol Cell Neurosci"},{"key":"1388_CR31","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/mt.2015.91","volume":"23","author":"S-G Cho","year":"2015","unstructured":"Cho S-G, Kim N, Sohn H-J, Lee SK, Oh ST, Lee H-J, Cho H-I, Yim HW, Jung SE, Park G (2015b) Long-term outcome of extranodal NK\/T cell lymphoma patients treated with postremission therapy using EBV LMP1 and LMP2a-specific CTLs. Mol Ther 23:1401\u20131409. https:\/\/doi.org\/10.1038\/mt.2015.91","journal-title":"Mol Ther"},{"key":"1388_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00705-016-3109-z","volume":"162","author":"H Choi","year":"2017","unstructured":"Choi H, Lee SK (2017) TAX1BP1 downregulation by EBV-miR-BART15-3p enhances chemosensitivity of gastric cancer cells to 5-FU. Arch Virol 162:369\u2013377. https:\/\/doi.org\/10.1007\/s00705-016-3109-z","journal-title":"Arch Virol"},{"key":"1388_CR33","doi-asserted-by":"publisher","first-page":"8135","DOI":"10.1128\/JVI.03159-12","volume":"87","author":"H Choi","year":"2013","unstructured":"Choi H, Lee H, Kim SR, Gho YS, Lee SK (2013) Epstein-Barr virus-encoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE. J Virol 87:8135\u20138144","journal-title":"J Virol"},{"key":"1388_CR34","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1084\/jem.20072581","volume":"205","author":"EY-W Choy","year":"2008","unstructured":"Choy EY-W, Siu K-L, Kok K-H, Lung RW-M, Tsang CM, To K-F, Kwong DL-W, Tsao SW, Jin D-Y (2008) An Epstein-Barr virus\u2013encoded microRNA targets PUMA to promote host cell survival. J Exp Med 205:2551\u20132560. https:\/\/doi.org\/10.1084\/jem.20072581","journal-title":"J Exp Med"},{"key":"1388_CR35","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1001\/jamaneurol.2024.0272","volume":"81","author":"M Cortese","year":"2024","unstructured":"Cortese M, Leng Y, Bjornevik K, Mitchell M, Healy BC, Mina MJ, Mancuso JD, Niebuhr DW, Munger KL, Elledge SJ (2024) Serologic response to the Epstein-Barr virus peptidome and the risk for multiple sclerosis. JAMA Neurol 81:515\u2013524","journal-title":"JAMA Neurol"},{"key":"1388_CR36","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1128\/jvi.02104-08","volume":"83","author":"K Cosmopoulos","year":"2009","unstructured":"Cosmopoulos K, Pegtel M, Hawkins J, Moffett H, Novina C, Middeldorp J, Thorley-Lawson DA (2009) Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J Virol 83:2357\u20132367. https:\/\/doi.org\/10.1128\/jvi.02104-08","journal-title":"J Virol"},{"key":"1388_CR37","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/v16071012","volume":"16","author":"IB Costa","year":"2024","unstructured":"Costa IB, Santana-da-Silva MN, Nogami PY, Santos e Santos CdJ, Pereira LMS, Fran\u00e7a EdS, Freire ABC, Ramos FLdP, Monteiro TAF, Macedo O (2024) Immunogenetic profile associated with patients living with HIV-1 and Epstein\u2013Barr virus (EBV) in the Brazilian Amazon region. Viruses 16:1012","journal-title":"Viruses"},{"key":"1388_CR38","doi-asserted-by":"publisher","first-page":"D147","DOI":"10.1093\/nar\/gkae1072","volume":"53","author":"S Cui","year":"2025","unstructured":"Cui S, Yu S, Huang H-Y, Lin Y-C-D, Huang Y, Zhang B, Xiao J, Zuo H, Wang J, Li Z, Li G, Ma J, Chen B, Zhang H, Fu J, Wang L, Huang H-D (2025) MiRTarBase 2025: updates to the collection of experimentally validated microRNA\u2013target interactions. Nucleic Acids Res 53:D147\u2013D156. https:\/\/doi.org\/10.1093\/nar\/gkae1072","journal-title":"Nucleic Acids Res"},{"key":"1388_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3722","volume":"15","author":"PE Czabotar","year":"2014","unstructured":"Czabotar PE, Lessene G, Strasser A, Adams JM (2014) Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 15:49\u201363. https:\/\/doi.org\/10.1038\/nrm3722","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1388_CR40","doi-asserted-by":"publisher","first-page":"57143","DOI":"10.12775\/QS.2025.37.57143","volume":"37","author":"W Czy\u017c","year":"2025","unstructured":"Czy\u017c W, Chuncia-Ilczeko M, W\u00f3jcikiewicz M, Arczewski F, Dziedzic K, Kulbacka J, Wojszczyk M, Zys D, Pasek P, Ryniecka J (2025) Epstein-Barr virus (EBV) and systemic lupus erythematosus (SLE) association in serological studies. Qual Sport 37:57143\u201357143. https:\/\/doi.org\/10.12775\/QS.2025.37.57143","journal-title":"Qual Sport"},{"key":"1388_CR41","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1128\/jvi.01888-07","volume":"82","author":"CW Dawson","year":"2008","unstructured":"Dawson CW, Laverick L, Morris MA, Tramoutanis G, Young LS (2008) Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway. J Virol 82:3654\u20133664. https:\/\/doi.org\/10.1128\/jvi.01888-07","journal-title":"J Virol"},{"key":"1388_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/849573","volume":"2015","author":"PS de Ara\u00fajo-Souza","year":"2015","unstructured":"de Ara\u00fajo-Souza PS, Hanschke SC, Viola JP (2015) Epigenetic control of interferon-gamma expression in CD8 T cells. J Immunol Res 2015:849573. https:\/\/doi.org\/10.1155\/2015\/849573","journal-title":"J Immunol Res"},{"key":"1388_CR43","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.1128\/JVI.79.8.4640-4650.2005","volume":"79","author":"Z Deng","year":"2005","unstructured":"Deng Z, Atanasiu C, Zhao K, Marmorstein R, Sbodio JI, Chi N-W, Lieberman PM (2005) Inhibition of Epstein-Barr virus OriP function by tankyrase, a telomere-associated poly-ADP ribose polymerase that binds and modifies EBNA1. J Virol 79:4640\u20134650","journal-title":"J Virol"},{"key":"1388_CR44","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.chom.2010.03.008","volume":"7","author":"L D\u00f6lken","year":"2010","unstructured":"D\u00f6lken L, Malterer G, Erhard F, Kothe S, Friedel CC, Suffert G, Marcinowski L, Motsch N, Barth S, Beitzinger M (2010) Systematic analysis of viral and cellular MicroRNA targets in cells latently infected with human \u03b3-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe 7:324\u2013334. https:\/\/doi.org\/10.1016\/j.chom.2010.03.008","journal-title":"Cell Host Microbe"},{"key":"1388_CR45","doi-asserted-by":"publisher","first-page":"e64921","DOI":"10.1371\/journal.pone.0064921","volume":"8","author":"JB Dowd","year":"2013","unstructured":"Dowd JB, Palermo T, Brite J, McDade TW, Aiello A (2013) Seroprevalence of Epstein-Barr virus infection in US children ages 6\u201319, 2003\u20132010. PLoS ONE 8:e64921. https:\/\/doi.org\/10.1371\/journal.pone.0064921","journal-title":"PLoS ONE"},{"key":"1388_CR46","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1080\/1744666x.2024.2328739","volume":"20","author":"S Eckert","year":"2024","unstructured":"Eckert S, Jakimovski D, Zivadinov R, Hicar M, Weinstock-Guttman B (2024) How to and should we target EBV in MS? Expert Rev Clin Immunol 20:703\u2013714. https:\/\/doi.org\/10.1080\/1744666x.2024.2328739","journal-title":"Expert Rev Clin Immunol"},{"key":"1388_CR47","doi-asserted-by":"publisher","first-page":"10329","DOI":"10.1128\/JVI.00923-10","volume":"84","author":"AL Ellis-Connell","year":"2010","unstructured":"Ellis-Connell AL, Iempridee T, Xu I, Mertz JE (2010) Cellular MicroRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication. J Virol 84:10329\u201310343","journal-title":"J Virol"},{"key":"1388_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-024-01619-4","volume":"15","author":"F Estaji","year":"2024","unstructured":"Estaji F, Zibaee S, Torabi M, Moghim S (2024) Epstein\u2013Barr virus and gastric carcinoma pathogenesis with emphasis on underlying epigenetic mechanisms. Discover Oncol 15:719. https:\/\/doi.org\/10.1007\/s12672-024-01619-4","journal-title":"Discover Oncol"},{"key":"1388_CR49","doi-asserted-by":"publisher","first-page":"e1001294","DOI":"10.1371\/journal.ppat.1001294","volume":"7","author":"R Feederle","year":"2011","unstructured":"Feederle R, Linnstaedt SD, Bannert H, Lips H, Bencun M, Cullen BR, Delecluse H-J (2011) A viral MicroRNA cluster strongly potentiates the transforming properties of a human herpesvirus. PLoS Pathog 7:e1001294. https:\/\/doi.org\/10.1371\/journal.ppat.1001294","journal-title":"PLoS Pathog"},{"key":"1388_CR50","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1101\/gr.083550.108","volume":"19","author":"AF Fernandez","year":"2009","unstructured":"Fernandez AF, Rosales C, Lopez-Nieva P, Gra\u00f1a O, Ballestar E, Ropero S, Espada J, Melo SA, Lujambio A, Fraga MF (2009) The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res 19:438\u2013451. https:\/\/doi.org\/10.1101\/gr.083550.108","journal-title":"Genome Res"},{"key":"1388_CR51","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1128\/jvi.66.8.5030-5039.1992","volume":"66","author":"ED Fixman","year":"1992","unstructured":"Fixman ED, Hayward GS, Hayward SD (1992) Trans-acting requirements for replication of Epstein-Barr virus ori-Lyt. J Virol 66:5030\u20135039. https:\/\/doi.org\/10.1128\/jvi.66.8.5030-5039.1992","journal-title":"J Virol"},{"key":"1388_CR52","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.micinf.2011.07.007","volume":"13","author":"E Forte","year":"2011","unstructured":"Forte E, Luftig MA (2011) The role of MicroRNAs in Epstein-Barr virus latency and lytic reactivation. Microbes Infect 13:1156\u20131167. https:\/\/doi.org\/10.1016\/j.micinf.2011.07.007","journal-title":"Microbes Infect"},{"key":"1388_CR53","doi-asserted-by":"publisher","first-page":"6889","DOI":"10.1128\/jvi.07056-11","volume":"86","author":"E Forte","year":"2012","unstructured":"Forte E, Salinas RE, Chang C, Zhou T, Linnstaedt SD, Gottwein E, Jacobs C, Jima D, Li Q-J, Dave SS (2012) The Epstein-Barr virus (EBV)-induced tumor suppressor MicroRNA miR-34a is growth promoting in EBV-infected B cells. J Virol 86:6889\u20136898. https:\/\/doi.org\/10.1128\/jvi.07056-11","journal-title":"J Virol"},{"key":"1388_CR54","first-page":"73","volume":"71","author":"M Fukayama","year":"1994","unstructured":"Fukayama M, Hayashi Y, Iwasaki Y, Chong J, Ooba T, Takizawa T, Koike M, Mizutani S, Miyaki M, Hirai K (1994) Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab Invest 71:73\u201381","journal-title":"Lab Invest"},{"key":"1388_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar1917","volume":"8","author":"C Gabay","year":"2006","unstructured":"Gabay C (2006) Interleukin-6 and chronic inflammation. Arthritis Res Ther 8:1\u20136. https:\/\/doi.org\/10.1186\/ar1917","journal-title":"Arthritis Res Ther"},{"key":"1388_CR56","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11940-024-00822-6","volume":"27","author":"G Giovannoni","year":"2025","unstructured":"Giovannoni G (2025) Epstein-Barr virus as a therapeutic and preventive target in multiple sclerosis. Curr Treat Options Neurol 27:10. https:\/\/doi.org\/10.1007\/s11940-024-00822-6","journal-title":"Curr Treat Options Neurol"},{"key":"1388_CR57","unstructured":"Godang NL, DeMeis JD, Houserova D, Chaudhary NY, Salter CJ, Xi Y, McDonald OG, Borchert GM (2023) Global switch from DICER-dependent MicroRNA to DICER-independent SnoRNA-derived RNA biogenesis in malignancy. Micropublication Biol 2023: 10.17912\/micropub. biology. 000725"},{"key":"1388_CR58","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.3390\/genes15101243","volume":"15","author":"H Goel","year":"2024","unstructured":"Goel H, Goel A (2024) MicroRNA and rare human diseases. Genes 15:1243. https:\/\/doi.org\/10.3390\/genes15101243","journal-title":"Genes"},{"key":"1388_CR59","doi-asserted-by":"publisher","first-page":"7349","DOI":"10.1128\/jvi.76.14.7349-7355.2002","volume":"76","author":"AV Gordadze","year":"2002","unstructured":"Gordadze AV, Poston D, Ling PD (2002) The EBNA2 polyproline region is dispensable for Epstein-Barr virus-mediated immortalization maintenance. J Virol 76:7349\u20137355. https:\/\/doi.org\/10.1128\/jvi.76.14.7349-7355.2002","journal-title":"J Virol"},{"key":"1388_CR60","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev-biodatasci-122220-111429","volume":"6","author":"V Gouzouasis","year":"2023","unstructured":"Gouzouasis V, Tastsoglou S, Giannakakis A, Hatzigeorgiou AG (2023) Virus-derived small RNAs and MicroRNAs in health and disease. Annu Rev Biomed Data Sci 6:275\u2013298. https:\/\/doi.org\/10.1146\/annurev-biodatasci-122220-111429","journal-title":"Annu Rev Biomed Data Sci"},{"key":"1388_CR61","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1158\/1078-0432.CCR-11-1942","volume":"18","author":"MR Green","year":"2012","unstructured":"Green MR, Rodig S, Juszczynski P, Ouyang J, Sinha P, O\u2019Donnell E, Neuberg D, Shipp MA (2012) Constitutive AP-1 activity and EBV infection induce PD-L1 in hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy. Clin Cancer Res 18:1611\u20131618. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-1942","journal-title":"Clin Cancer Res"},{"key":"1388_CR62","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a013029","volume":"5","author":"W Hammerschmidt","year":"2013","unstructured":"Hammerschmidt W, Sugden B (2013) Replication of Epstein\u2013Barr viral DNA. Cold Spring Harb Perspect Biol 5:a013029","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1388_CR63","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.4049\/jimmunol.1200312","volume":"189","author":"M Haneklaus","year":"2012","unstructured":"Haneklaus M, Gerlic M, Kurowska-Stolarska M, Rainey AA, Pich D, McInnes IB, Hammerschmidt W, O\u2019Neill LA, Masters SL (2012) Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1\u03b2 production. J Immunol 189:3795\u20133799. https:\/\/doi.org\/10.4049\/jimmunol.1200312","journal-title":"J Immunol"},{"key":"1388_CR64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/0952-7915(91)90068-C","volume":"3","author":"CV Harding","year":"1991","unstructured":"Harding CV (1991) Pathways of antigen processing. Curr Opin Immunol 3:3\u20139. https:\/\/doi.org\/10.1016\/0952-7915(91)90068-C","journal-title":"Curr Opin Immunol"},{"key":"1388_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-016-0602-7","volume":"13","author":"C Harold","year":"2016","unstructured":"Harold C, Cox D, Riley KJ (2016) Epstein-Barr viral MicroRNAs target caspase 3. Virol J 13:1\u20138. https:\/\/doi.org\/10.1186\/s12985-016-0602-7","journal-title":"Virol J"},{"key":"1388_CR66","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1080\/15476286.2021.1880756","volume":"18","author":"G He","year":"2021","unstructured":"He G, Ding J, Zhang Ye, Cai M, Yang J, Cho WC, Zheng Y (2021) MicroRNA-21: a key modulator in oncogenic viral infections. RNA Biol 18:809\u2013817. https:\/\/doi.org\/10.1080\/15476286.2021.1880756","journal-title":"RNA Biol"},{"key":"1388_CR67","doi-asserted-by":"publisher","first-page":"5151","DOI":"10.1128\/jvi.06760-11","volume":"86","author":"AM Heilmann","year":"2012","unstructured":"Heilmann AM, Calderwood MA, Portal D, Lu Y, Johannsen E (2012) Genome-wide analysis of Epstein-Barr virus Rta DNA binding. J Virol 86:5151\u20135164. https:\/\/doi.org\/10.1128\/jvi.06760-11","journal-title":"J Virol"},{"key":"1388_CR68","doi-asserted-by":"publisher","first-page":"8576","DOI":"10.4049\/jimmunol.181.12.8576","volume":"181","author":"CJ Henry","year":"2008","unstructured":"Henry CJ, Ornelles DA, Mitchell LM, Brzoza-Lewis KL, Hiltbold EM (2008) IL-12 produced by dendritic cells augments CD8\u2009+\u2009T cell activation through the production of the chemokines CCL1 and CCL17. J Immunol 181:8576\u20138584","journal-title":"J Immunol"},{"key":"1388_CR69","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nmeth.2633","volume":"10","author":"CM Hindson","year":"2013","unstructured":"Hindson CM, Chevillet JR, Briggs HA, Gallichotte EN, Ruf IK, Hindson BJ, Vessella RL, Tewari M (2013) Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods 10:1003\u20131005. https:\/\/doi.org\/10.1038\/nmeth.2633","journal-title":"Nat Methods"},{"key":"1388_CR70","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3390\/v15020423","volume":"15","author":"JW Ho","year":"2023","unstructured":"Ho JW, Li L, Wong KY, Srivastava G, Tao Q (2023) Comprehensive profiling of EBV gene expression and promoter methylation reveals latency II viral infection and sporadic abortive lytic activation in peripheral T-cell lymphomas. Viruses 15:423. https:\/\/doi.org\/10.3390\/v15020423","journal-title":"Viruses"},{"key":"1388_CR71","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.4049\/jimmunol.1501605","volume":"198","author":"MJG Hooykaas","year":"2017","unstructured":"Hooykaas MJG, van Gent M, Soppe JA, Kruse E, Boer IGJ, van Leenen D, Groot Koerkamp MJA, Holstege FCP, Ressing ME, Wiertz E, Lebbink RJ (2017) EBV microRNA BART16 suppresses type I IFN signaling. J Immunol 198:4062\u20134073. https:\/\/doi.org\/10.4049\/jimmunol.1501605","journal-title":"J Immunol"},{"key":"1388_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003974","volume":"10","author":"C-Y Hsu","year":"2014","unstructured":"Hsu C-Y, Yi Y-H, Chang K-P, Chang Y-S, Chen S-J, Chen H-C (2014) The Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma. PLoS Pathog 10:e1003974","journal-title":"PLoS Pathog"},{"key":"1388_CR73","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.ajpath.2013.12.024","volume":"184","author":"WT Huang","year":"2014","unstructured":"Huang WT, Lin CW (2014) EBV-encoded miR-BART20-5p and miR-BART8 inhibit the IFN-\u03b3-STAT1 pathway associated with disease progression in nasal NK-cell lymphoma. Am J Pathol 184:1185\u20131197. https:\/\/doi.org\/10.1016\/j.ajpath.2013.12.024","journal-title":"Am J Pathol"},{"key":"1388_CR74","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1093\/brain\/awae110","volume":"147","author":"J Huang","year":"2024","unstructured":"Huang J, Tengvall K, Lima IB, Hedstr\u00f6m AK, Butt J, Brenner N, Gyllenberg A, Stridh P, Khademi M, Ernberg I, Al Nimer F, Manouchehrinia A, Hillert J, Alfredsson L, Andersen O, Sundstr\u00f6m P, Waterboer T, Olsson T, Kockum I (2024) Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis. Brain 147:3573\u20133582. https:\/\/doi.org\/10.1093\/brain\/awae110","journal-title":"Brain"},{"key":"1388_CR75","doi-asserted-by":"publisher","first-page":"33358","DOI":"10.1074\/jbc.M110.138362","volume":"285","author":"H Iizasa","year":"2010","unstructured":"Iizasa H, Wulff B-E, Alla NR, Maragkakis M, Megraw M, Hatzigeorgiou A, Iwakiri D, Takada K, Wiedmer A, Showe L (2010) Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency. J Biol Chem 285:33358\u201333370. https:\/\/doi.org\/10.1074\/jbc.M110.138362","journal-title":"J Biol Chem"},{"key":"1388_CR76","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3389\/fimmu.2020.00367","volume":"11","author":"H Iizasa","year":"2020","unstructured":"Iizasa H, Kim H, Kartika AV, Kanehiro Y, Yoshiyama H (2020) Role of viral and host MicroRNAs in immune regulation of Epstein-Barr virus-associated diseases. Front Immunol 11:367","journal-title":"Front Immunol"},{"key":"1388_CR77","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1093\/nar\/gkq1043","volume":"39","author":"J Imig","year":"2011","unstructured":"Imig J, Motsch N, Zhu JY, Barth S, Okoniewski M, Reineke T, Tinguely M, Faggioni A, Trivedi P, Meister G (2011) MicroRNA profiling in Epstein\u2013Barr virus-associated B-cell lymphoma. Nucleic Acids Res 39:1880\u20131893. https:\/\/doi.org\/10.1093\/nar\/gkq1043","journal-title":"Nucleic Acids Res"},{"key":"1388_CR78","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1016\/j.jmb.2017.09.012","volume":"429","author":"RS Isaac","year":"2017","unstructured":"Isaac RS, Sanulli S, Tibble R, Hornsby M, Ravalin M, Craik CS, Gross JD, Narlikar GJ (2017) Biochemical basis for distinct roles of the heterochromatin proteins Swi6 and Chp2. J Mol Biol 429:3666\u20133677. https:\/\/doi.org\/10.1016\/j.jmb.2017.09.012","journal-title":"J Mol Biol"},{"key":"1388_CR79","doi-asserted-by":"publisher","first-page":"9027","DOI":"10.1128\/jvi.00721-14","volume":"88","author":"Y-J Jung","year":"2014","unstructured":"Jung Y-J, Choi H, Kim H, Lee SK (2014) MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1. J Virol 88:9027\u20139037. https:\/\/doi.org\/10.1128\/jvi.00721-14","journal-title":"J Virol"},{"key":"1388_CR80","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1128\/jvi.03189-14","volume":"89","author":"T Kanda","year":"2015","unstructured":"Kanda T, Miyata M, Kano M, Kondo S, Yoshizaki T, Iizasa H (2015) Clustered MicroRNAs of the Epstein-Barr virus cooperatively downregulate an epithelial cell-specific metastasis suppressor. J Virol 89:2684\u20132697. https:\/\/doi.org\/10.1128\/jvi.03189-14","journal-title":"J Virol"},{"key":"1388_CR81","doi-asserted-by":"publisher","first-page":"e1004979","DOI":"10.1371\/journal.ppat.1004979","volume":"11","author":"D Kang","year":"2015","unstructured":"Kang D, Skalsky RL, Cullen BR (2015) EBV BART MicroRNAs target multiple pro-apoptotic cellular genes to promote epithelial cell survival. PLoS Pathog 11:e1004979","journal-title":"PLoS Pathog"},{"key":"1388_CR82","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baad014","volume":"2023","author":"D Kariuki","year":"2023","unstructured":"Kariuki D, Asam K, Aouizerat BE, Lewis KA, Florez JC, Flowers E (2023) Review of databases for experimentally validated human microRNA\u2013mRNA interactions. Database 2023:baad014. https:\/\/doi.org\/10.1093\/database\/baad014","journal-title":"Database"},{"key":"1388_CR83","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.semcancer.2014.01.002","volume":"26","author":"SC Kenney","year":"2014","unstructured":"Kenney SC, Mertz JE (2014) Regulation of the latent-lytic switch in Epstein\u2013Barr virus. Semin Cancer Biol 26:60\u201368. https:\/\/doi.org\/10.1016\/j.semcancer.2014.01.002","journal-title":"Semin Cancer Biol"},{"key":"1388_CR84","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1128\/jvi.02271-06","volume":"81","author":"DN Kim","year":"2007","unstructured":"Kim DN, Chae H-S, Oh ST, Kang J-H, Park CH, Park WS, Takada K, Lee JM, Lee W-K, Lee SK (2007) Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol 81:1033\u20131036. https:\/\/doi.org\/10.1128\/jvi.02271-06","journal-title":"J Virol"},{"key":"1388_CR85","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.canlet.2014.10.023","volume":"356","author":"H Kim","year":"2015","unstructured":"Kim H, Choi H, Lee SK (2015) Epstein\u2013Barr virus miR-BART20-5p regulates cell proliferation and apoptosis by targeting BAD. Cancer Lett 356:733\u2013742. https:\/\/doi.org\/10.1016\/j.canlet.2014.10.023","journal-title":"Cancer Lett"},{"key":"1388_CR86","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1128\/JVI.02794-15","volume":"90","author":"H Kim","year":"2016","unstructured":"Kim H, Choi H, Lee SK (2016) Epstein-Barr virus microRNA miR-BART20-5p suppresses lytic induction by inhibiting BAD-mediated caspase-3-dependent apoptosis. J Virol 90:1359\u20131368","journal-title":"J Virol"},{"key":"1388_CR87","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s10120-023-01445-7","volume":"27","author":"EJ Kim","year":"2024","unstructured":"Kim EJ, Chae H, Park Y-S, Ryu M-H, Kim H-D, Shin J, Park YS, Moon MS, Kang Y-K (2024) Clinical outcomes of Epstein\u2013Barr virus (EBV)-associated metastatic and locally advanced unresectable gastric cancers (GCs) in patients receiving first-line fluoropyrimidine and platinum (FP) doublet chemotherapy. Gastric Cancer 27:146\u2013154. https:\/\/doi.org\/10.1007\/s10120-023-01445-7","journal-title":"Gastric Cancer"},{"key":"1388_CR88","doi-asserted-by":"publisher","first-page":"1342455","DOI":"10.3389\/fimmu.2024.1342455","volume":"15","author":"IY Kong","year":"2024","unstructured":"Kong IY, Giulino-Roth L (2024) Targeting latent viral infection in EBV-associated lymphomas. Front Immunol 15:1342455. https:\/\/doi.org\/10.3389\/fimmu.2024.1342455","journal-title":"Front Immunol"},{"key":"1388_CR89","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2174\/0113892010241606231003102047","volume":"25","author":"M Kumar","year":"2024","unstructured":"Kumar M, Sahoo GC, Das VNR, Singh K, Pandey K (2024) A review of miRNA regulation in Japanese encephalitis (JEV) virus infection. Curr Pharm Biotechnol 25:521\u2013533. https:\/\/doi.org\/10.2174\/0113892010241606231003102047","journal-title":"Curr Pharm Biotechnol"},{"key":"1388_CR90","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.omtn.2023.02.012","volume":"31","author":"MN Le","year":"2023","unstructured":"Le MN, Nguyen TA (2023) Innovative microRNA quantification by qPCR. Mol Ther Nucleic Acids 31:628\u2013630. https:\/\/doi.org\/10.1016\/j.omtn.2023.02.012","journal-title":"Mol Ther Nucleic Acids"},{"key":"1388_CR91","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ijc.28007","volume":"133","author":"T Lei","year":"2013","unstructured":"Lei T, Yuen KS, Xu R, Tsao SW, Chen H, Li M, Kok KH, Jin DY (2013) Targeting of DICE1 tumor suppressor by Epstein\u2013Barr virus-encoded miR\u2010BART3* microRNA in nasopharyngeal carcinoma. Int J Cancer 133:79\u201387. https:\/\/doi.org\/10.1002\/ijc.28007","journal-title":"Int J Cancer"},{"key":"1388_CR92","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.canlet.2010.07.021","volume":"299","author":"G Li","year":"2010","unstructured":"Li G, Wu Z, Peng Y, Liu X, Lu J, Wang L, Pan Q, He M-L, Li X-P (2010) MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells. Cancer Lett 299:29\u201336. https:\/\/doi.org\/10.1016\/j.canlet.2010.07.021","journal-title":"Cancer Lett"},{"key":"1388_CR93","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.biocel.2011.11.007","volume":"44","author":"Z Li","year":"2012","unstructured":"Li Z, Chen X, Li L, Liu S, Yang L, Ma X, Tang M, Bode AM, Dong Z, Sun L (2012) EBV encoded miR-BHRF1-1 potentiates viral lytic replication by downregulating host p53 in nasopharyngeal carcinoma. Int J Biochem Cell Biol 44:275\u2013279. https:\/\/doi.org\/10.1016\/j.biocel.2011.11.007","journal-title":"Int J Biochem Cell Biol"},{"key":"1388_CR94","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.7150\/ijbs.16564","volume":"12","author":"H Li","year":"2016","unstructured":"Li H, Liu S, Hu J, Luo X, Li N, MBode A, Cao Y (2016) Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis. Int J Biol Sci 12:1309. https:\/\/doi.org\/10.7150\/ijbs.16564","journal-title":"Int J Biol Sci"},{"key":"1388_CR95","doi-asserted-by":"publisher","first-page":"e1005344","DOI":"10.1371\/journal.ppat.1005344","volume":"11","author":"X Lin","year":"2015","unstructured":"Lin X, Tsai M-H, Shumilov A, Poirey R, Bannert H, Middeldorp JM, Feederle R, Delecluse H-J (2015) The Epstein-Barr virus BART miRNA cluster of the M81 strain modulates multiple functions in primary B cells. PLoS Pathog 11:e1005344","journal-title":"PLoS Pathog"},{"key":"1388_CR96","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1128\/jvi.02830-15","volume":"90","author":"Z Lin","year":"2016","unstructured":"Lin Z, Swan K, Zhang X, Cao S, Brett Z, Drury S, Strong MJ, Fewell C, Puetter A, Wang X (2016) Secreted oral epithelial cell membrane vesicles induce Epstein-Barr virus reactivation in latently infected B cells. J Virol 90:3469\u20133479. https:\/\/doi.org\/10.1128\/jvi.02830-15","journal-title":"J Virol"},{"key":"1388_CR97","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01378-22","volume":"11","author":"K Lin","year":"2023","unstructured":"Lin K, Zhao Y, Xu B, Yu S, Fu Z, Zhang Y, Wang H, Song J, Fan M, Zhou Y, Ai J, Qiu C, Zhang H, Zhang W (2023) Clinical diagnostic performance of droplet digital PCR for suspected bloodstream infections. Microbiol Spectr 11:e01378-01322. https:\/\/doi.org\/10.1128\/spectrum.01378-22","journal-title":"Microbiol Spectr"},{"key":"1388_CR98","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00705-024-06095-3","volume":"169","author":"C Liu","year":"2024","unstructured":"Liu C, Li S, Qiao M, Zeng C, Liu X, Tang Y (2024a) GB and gH\/gL fusion machinery: a promising target for vaccines to prevent Epstein-Barr virus infection. Arch Virol 169:167. https:\/\/doi.org\/10.1007\/s00705-024-06095-3","journal-title":"Arch Virol"},{"key":"1388_CR99","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae464","volume":"11","author":"K-L Liu","year":"2024","unstructured":"Liu K-L, Hsu W-L, Bu W, Yu KJ, Wang C-P, Chien Y-C, Chen T-C, Chen C-J, Hildesheim A, Middeldorp JM (2024b) Association between antibodies that bind Epstein-Barr virus (EBV) gp350 and gH\/gL and shedding of EBV in saliva from nasopharyngeal carcinoma multiplex family members in Taiwan. Open Forum Infect Dis 11:ofae464. https:\/\/doi.org\/10.1093\/ofid\/ofae464","journal-title":"Open Forum Infect Dis"},{"key":"1388_CR100","doi-asserted-by":"publisher","first-page":"16164","DOI":"10.1073\/pnas.0702896104","volume":"104","author":"AKF Lo","year":"2007","unstructured":"Lo AKF, To KF, Lo KW, Lung RWM, Hui JWY, Liao G, Hayward SD (2007) Modulation of LMP1 protein expression by EBV-encoded MicroRNAs. Proc Natl Acad Sci 104:16164\u201316169","journal-title":"Proc Natl Acad Sci"},{"key":"1388_CR101","doi-asserted-by":"publisher","first-page":"10436","DOI":"10.1128\/jvi.00752-08","volume":"82","author":"F Lu","year":"2008","unstructured":"Lu F, Weidmer A, Liu C-G, Volinia S, Croce CM, Lieberman PM (2008) Epstein-Barr virus-induced miR-155 attenuates NF-\u03baB signaling and stabilizes latent virus persistence. J Virol 82:10436\u201310443. https:\/\/doi.org\/10.1128\/jvi.00752-08","journal-title":"J Virol"},{"key":"1388_CR102","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1159\/000479749","volume":"9","author":"Y Lu","year":"2017","unstructured":"Lu Y, Qin Z, Wang J, Zheng X, Lu J, Zhang X, Wei L, Peng Q, Zheng Y, Ou C, Ye Q, Xiong W, Li G, Fu Y, Yan Q, Ma J (2017) Epstein-Barr virus miR-BART6-3p inhibits the RIG-I pathway. J Innate Immun 9:574\u2013586. https:\/\/doi.org\/10.1159\/000479749","journal-title":"J Innate Immun"},{"key":"1388_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17040475","volume":"17","author":"N Ludwig","year":"2016","unstructured":"Ludwig N, Werner TV, Backes C, Trampert P, Gessler M, Keller A, Lenhof H-P, Graf N, Meese E (2016) Combining miRNA and mRNA expression profiles in Wilms tumor subtypes. Int J Mol Sci 17:475. https:\/\/doi.org\/10.3390\/ijms17040475","journal-title":"Int J Mol Sci"},{"key":"1388_CR104","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1593\/neo.09888","volume":"11","author":"RW-M Lung","year":"2009","unstructured":"Lung RW-M, Tong JH-M, Sung Y-M, Leung P-S, Ng DC-H, Chau S-L, Chan AW-H, Ng EK-O, Lo K-W, To K-F (2009) Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia 11:1174","journal-title":"Neoplasia"},{"key":"1388_CR105","doi-asserted-by":"publisher","first-page":"17378","DOI":"10.3390\/ijms140917378","volume":"14","author":"RW-M Lung","year":"2013","unstructured":"Lung RW-M, Tong JH-M, To K-F (2013) Emerging roles of small Epstein-Barr virus derived non-coding RNAs in epithelial malignancy. Int J Mol Sci 14:17378\u201317409. https:\/\/doi.org\/10.3390\/ijms140917378","journal-title":"Int J Mol Sci"},{"key":"1388_CR106","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10529-011-0813-3","volume":"34","author":"X Luo","year":"2012","unstructured":"Luo X, Zhang J, Wang H, Du Y, Yang L, Zheng F, Ma D (2012) PolyA RT-PCR-based quantification of microRNA by using universal TaqMan probe. Biotechnol Lett 34:627\u2013633. https:\/\/doi.org\/10.1007\/s10529-011-0813-3","journal-title":"Biotechnol Lett"},{"key":"1388_CR107","doi-asserted-by":"publisher","first-page":"e00022","DOI":"10.1128\/cmr.00022-23","volume":"37","author":"KA Lurain","year":"2024","unstructured":"Lurain KA, Ramaswami R, Krug LT, Whitby D, Ziegelbauer JM, Wang H-W, Yarchoan R (2024) HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus. Clin Microbiol Rev 37:e00022\u201300023","journal-title":"Clin Microbiol Rev"},{"key":"1388_CR108","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1128\/JVI.01512-10","volume":"85","author":"S-D Ma","year":"2011","unstructured":"Ma S-D, Hegde S, Young KH, Sullivan R, Rajesh D, Zhou Y, Jankowska-Gan E, Burlingham WJ, Sun X, Gulley ML (2011) A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J Virol 85:165\u2013177","journal-title":"J Virol"},{"key":"1388_CR109","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/leu.2015.285","volume":"30","author":"J Ma","year":"2016","unstructured":"Ma J, Nie K, Redmond D, Liu Y, Elemento O, Knowles DM, Tam W (2016) EBV-miR-BHRF1-2 targets PRDM1\/Blimp1: potential role in EBV lymphomagenesis. Leukemia 30:594\u2013604. https:\/\/doi.org\/10.1038\/leu.2015.285","journal-title":"Leukemia"},{"key":"1388_CR110","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S1470-2045(23)00649-6","volume":"25","author":"KM Mahadeo","year":"2024","unstructured":"Mahadeo KM, Baiocchi R, Beitinjaneh A, Chaganti S, Choquet S, Dierickx D, Dinavahi R, Duan X, Gamelin L, Ghobadi A (2024) Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein\u2013Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial. Lancet Oncol 25:376\u2013387. https:\/\/doi.org\/10.1016\/S1470-2045(23)00649-6","journal-title":"Lancet Oncol"},{"key":"1388_CR111","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.virol.2011.01.028","volume":"412","author":"AR Marquitz","year":"2011","unstructured":"Marquitz AR, Mathur A, Nam CS, Raab-Traub N (2011) The Epstein\u2013Barr virus BART MicroRNAs target the pro-apoptotic protein Bim. Virology 412:392\u2013400. https:\/\/doi.org\/10.1016\/j.virol.2011.01.028","journal-title":"Virology"},{"key":"1388_CR112","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-3-319-22834-1_8","volume":"2","author":"J McKenzie","year":"2015","unstructured":"McKenzie J, El-Guindy A (2015) Epstein-Barr virus lytic cycle reactivation. Epstein barr virus 2: one herpes virus: many diseases. Springer 2:237\u2013261. https:\/\/doi.org\/10.1007\/978-3-319-22834-1_8","journal-title":"Springer"},{"key":"1388_CR113","doi-asserted-by":"publisher","first-page":"R64","DOI":"10.1186\/gb-2009-10-6-r64","volume":"10","author":"P Mestdagh","year":"2009","unstructured":"Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Speleman F, Vandesompele J (2009) A novel and universal method for MicroRNA RT-qPCR data normalization. Genome Biol 10:R64. https:\/\/doi.org\/10.1186\/gb-2009-10-6-r64","journal-title":"Genome Biol"},{"key":"1388_CR114","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/cmi.2014.129","volume":"12","author":"B-P Miao","year":"2015","unstructured":"Miao B-P, Zhang R-S, Li M, Fu Y-T, Zhao M, Liu Z-G, Yang P-C (2015) Nasopharyngeal cancer-derived microRNA-21 promotes immune suppressive B cells. Cell Mol Immunol 12:750\u2013756. https:\/\/doi.org\/10.1038\/cmi.2014.129","journal-title":"Cell Mol Immunol"},{"key":"1388_CR115","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/nm1209-1363","volume":"15","author":"KHG Mills","year":"2009","unstructured":"Mills KHG, Dunne A (2009) Immune modulation: IL-1, master mediator or initiator of inflammation. Nat Med 15:1363\u20131364. https:\/\/doi.org\/10.1038\/nm1209-1363","journal-title":"Nat Med"},{"key":"1388_CR116","doi-asserted-by":"publisher","first-page":"657","DOI":"10.7150\/ijbs.30099","volume":"15","author":"K Min","year":"2019","unstructured":"Min K, Lee SK (2019) EBV miR-BART10-3p promotes cell proliferation and migration by targeting DKK1. Int J Biol Sci 15:657\u2013667. https:\/\/doi.org\/10.7150\/ijbs.30099","journal-title":"Int J Biol Sci"},{"key":"1388_CR117","doi-asserted-by":"publisher","first-page":"694","DOI":"10.7150\/ijbs.36595","volume":"16","author":"K Min","year":"2020","unstructured":"Min K, Kim JY, Lee SK (2020) Epstein-Barr virus miR-BART1-3p suppresses apoptosis and promotes migration of gastric carcinoma cells by targeting DAB2. Int J Biol Sci 16:694. https:\/\/doi.org\/10.7150\/ijbs.36595","journal-title":"Int J Biol Sci"},{"key":"1388_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fviro.2024.1485608","volume":"4","author":"G Mishra","year":"2025","unstructured":"Mishra G, Sarnaik G, Samanta J, Keche A, Negi SS (2025) The probable progression of Epstein-Barr virus (EBV) to chronic active EBV\/reactivation weakens the immune response and stimulates Cryptococcus neoformans infection, which invariably proves fatal: a case report and review of the literature. Front Virol 4:1485608. https:\/\/doi.org\/10.3389\/fviro.2024.1485608","journal-title":"Front Virol"},{"key":"1388_CR119","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1177\/10668969231195068","volume":"32","author":"S Mitra","year":"2024","unstructured":"Mitra S, Hanumanthappa MK, Sarkar S, Bhalla A, Minz R, Ratho RK (2024) Epstein barr virus-related acute liver failure and hemophagocytosis in an immunocompetent individual: an autopsy report. Int J Surg Pathol 32:838\u2013844. https:\/\/doi.org\/10.1177\/10668969231195068","journal-title":"Int J Surg Pathol"},{"key":"1388_CR120","doi-asserted-by":"publisher","first-page":"811","DOI":"10.2217\/fon.09.53","volume":"5","author":"MA Morris","year":"2009","unstructured":"Morris MA, Dawson CW, Young LS (2009) Role of the Epstein\u2013Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma. Fut Oncol 5:811\u2013825. https:\/\/doi.org\/10.2217\/fon.09.53","journal-title":"Fut Oncol"},{"issue":"8","key":"1388_CR121","doi-asserted-by":"publisher","first-page":"e42193","DOI":"10.1371\/journal.pone.0042193","volume":"7","author":"N Motsch","year":"2012","unstructured":"Motsch N, Alles J, Imig J, Zhu J, Barth S, Reineke T, Tinguely M, Cogliatti S, Dueck A, Meister G (2012) MicroRNA profiling of Epstein-Barr virus-associated NK\/T-cell lymphomas by deep sequencing. PLoS One 7(8):e42193. https:\/\/doi.org\/10.1371\/journal.pone.0042193","journal-title":"PLoS One"},{"key":"1388_CR122","doi-asserted-by":"publisher","first-page":"65","DOI":"10.20407\/fmj.2022-018","volume":"9","author":"T Murata","year":"2023","unstructured":"Murata T (2023) Epstein-Barr virus: the molecular virology and the associated diseases. Fujita Med J 9:65\u201372. https:\/\/doi.org\/10.20407\/fmj.2022-018","journal-title":"Fujita Med J"},{"key":"1388_CR123","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/rmv.1780","volume":"24","author":"T Murata","year":"2014","unstructured":"Murata T, Tsurumi T (2014) Switching of EBV cycles between latent and lytic states. Rev Med Virol 24:142\u2013153. https:\/\/doi.org\/10.1002\/rmv.1780","journal-title":"Rev Med Virol"},{"key":"1388_CR124","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.chom.2009.03.003","volume":"5","author":"D Nachmani","year":"2009","unstructured":"Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O (2009) Diverse herpesvirus MicroRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 5:376\u2013385. https:\/\/doi.org\/10.1016\/j.chom.2009.03.003","journal-title":"Cell Host Microbe"},{"key":"1388_CR125","doi-asserted-by":"publisher","DOI":"10.4103\/1477-3163.78111","volume":"10","author":"R Najdi","year":"2011","unstructured":"Najdi R, Holcombe RF, Waterman ML (2011) Wnt signaling and colon carcinogenesis: beyond APC. J Carcinog 10:5. https:\/\/doi.org\/10.4103\/1477-3163.78111","journal-title":"J Carcinog"},{"key":"1388_CR126","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.57239\/PJLSS-2024-22.1.00403","volume":"22","author":"OH Nsaif","year":"2024","unstructured":"Nsaif OH, Froushani SMA, Abood WN (2024) Detection the level of CD19, COX2, INF gamma, and prostaglandin (E2) in chronic active Epstein Barr virus at acute inflammation patients. Pak J Life Soc Sci 22:5465\u20135473. https:\/\/doi.org\/10.57239\/PJLSS-2024-22.1.00403","journal-title":"Pak J Life Soc Sci"},{"key":"1388_CR127","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2561","volume":"34","author":"LOD Oliveira","year":"2024","unstructured":"Oliveira LOD, Costa IB, Quaresma JAS (2024) Association between Epstein-Barr virus LMP\u20101 and Hodgkin lymphoma LMP\u20101 mechanisms in Hodgkin lymphoma development. Rev Med Virol 34:e2561. https:\/\/doi.org\/10.1002\/rmv.2561","journal-title":"Rev Med Virol"},{"key":"1388_CR128","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3390\/v16111759","volume":"16","author":"RAV Oliveira Neto NFd, Caixeta","year":"2024","unstructured":"Oliveira Neto NFd, Caixeta RAV, Zerbinati RM, Zarpellon AC, Caetano MW, Pallos D, Junges R, Costa ALF, Aitken-Saavedra J, Giannecchini S (2024) The emergence of saliva as a diagnostic and prognostic tool for viral infections. Viruses 16:1759. https:\/\/doi.org\/10.3390\/v16111759","journal-title":"Viruses"},{"key":"1388_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.104149","volume":"68","author":"O Olmez","year":"2022","unstructured":"Olmez O, Baba C, Abasiyanik Z, Ozakbas S (2022) Epstein-Barr virus antibody in newly diagnosed multiple sclerosis patients and its association with relapse severity and lesion location. Multiple Sclerosis and Related Disorders 68:104149. https:\/\/doi.org\/10.1016\/j.msard.2022.104149","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"1388_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087407","author":"OD Ortega-Hernandez","year":"2023","unstructured":"Ortega-Hernandez OD, Mart\u00ednez-C\u00e1ceres EM, Presas-Rodr\u00edguez S, Ramo-Tello C (2023) Epstein-Barr virus and multiple sclerosis: a convoluted interaction and the opportunity to unravel predictive biomarkers. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24087407","journal-title":"Int J Mol Sci"},{"key":"1388_CR131","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.semcancer.2004.06.009","volume":"14","author":"JS Pagano","year":"2004","unstructured":"Pagano JS, Blaser M, Buendia M-A, Damania B, Khalili K, Raab-Traub N, Roizman B (2004) Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol 14:453\u2013471. https:\/\/doi.org\/10.1016\/j.semcancer.2004.06.009","journal-title":"Semin Cancer Biol"},{"key":"1388_CR132","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/rai2.12155","volume":"4","author":"M Pan","year":"2024","unstructured":"Pan M, Yang J, Jiang Z (2024) Inflammasomes and their roles in autoimmune diseases. Rheumatology & Autoimmunity 4:197\u2013217. https:\/\/doi.org\/10.1002\/rai2.12155","journal-title":"Rheumatology & Autoimmunity"},{"key":"1388_CR133","doi-asserted-by":"publisher","first-page":"10936","DOI":"10.3390\/ijms222010936","volume":"22","author":"MC Park","year":"2021","unstructured":"Park MC, Kim H, Choi H, Chang MS, Lee SK (2021) Epstein-Barr virus miR-BART1-3p regulates the miR-17-92 cluster by targeting E2F3. Int J Mol Sci 22:10936. https:\/\/doi.org\/10.3390\/ijms222010936","journal-title":"Int J Mol Sci"},{"key":"1388_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7759\/cureus.26314","volume":"14","author":"PD Patel","year":"2022","unstructured":"Patel PD, Alghareeb R, Hussain A, Maheshwari MV, Khalid N (2022) The association of Epstein-Barr virus with cancer. Cureus 14:1\u20137. https:\/\/doi.org\/10.7759\/cureus.26314","journal-title":"Cureus"},{"key":"1388_CR135","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.molcel.2006.01.006","volume":"21","author":"C Petosa","year":"2006","unstructured":"Petosa C, Morand P, Baudin F, Moulin M, Artero J-B, M\u00fcller CW (2006) Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein. Mol Cell 21:565\u2013572. https:\/\/doi.org\/10.1016\/j.molcel.2006.01.006","journal-title":"Mol Cell"},{"key":"1388_CR136","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1126\/science.1096781","volume":"304","author":"S Pfeffer","year":"2004","unstructured":"Pfeffer S, Zavolan M, Gr\u00e4sser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C (2004) Identification of virus-encoded microRNAs. Science 304:734\u2013736. https:\/\/doi.org\/10.1126\/science.1096781","journal-title":"Science"},{"key":"1388_CR137","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jviromet.2018.06.015","volume":"259","author":"TF Pinheiro-de-Oliveira","year":"2018","unstructured":"Pinheiro-de-Oliveira TF, Fonseca AA, Camargos MF, Laguardia-Nascimento M, de Oliveira AM, Cottorello ACP, Goes-Neto A, Barbosa-Stancioli EF (2018) Development of a droplet digital RT-PCR for the quantification of foot-and-mouth virus RNA. J Virol Methods 259:129\u2013134. https:\/\/doi.org\/10.1016\/j.jviromet.2018.06.015","journal-title":"J Virol Methods"},{"key":"1388_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2024.116270","volume":"225","author":"M Pociupany","year":"2024","unstructured":"Pociupany M, Snoeck R, Dierickx D, Andrei G (2024) Treatment of Epstein-Barr virus infection in immunocompromised patients. Biochem Pharmacol 225:116270. https:\/\/doi.org\/10.1016\/j.bcp.2024.116270","journal-title":"Biochem Pharmacol"},{"key":"1388_CR139","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.virol.2017.09.015","volume":"512","author":"BC Poling","year":"2017","unstructured":"Poling BC, Price AM, Luftig MA, Cullen BR (2017) The Epstein-Barr virus miR-BHRF1 microRNAs regulate viral gene expression in cis. Virology 512:113\u2013123. https:\/\/doi.org\/10.1016\/j.virol.2017.09.015","journal-title":"Virology"},{"key":"1388_CR140","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12985-024-02452-5","volume":"21","author":"Q Pu","year":"2024","unstructured":"Pu Q, Dai Y, Hu N, Tao Z, Shi P, Jiang N, Shi L, Fang Z, Wang R, Hu X (2024) Early predictors of Epstein-Barr virus infection in patients with severe fever with thrombocytopenia syndrome. Virol J 21:179. https:\/\/doi.org\/10.1186\/s12985-024-02452-5","journal-title":"Virol J"},{"key":"1388_CR141","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1080\/21655979.2019.1679698","volume":"10","author":"Y Qiao","year":"2019","unstructured":"Qiao Y, Zhao X, Liu J, Yang W (2019) Epstein-barr virus circrnaome as host miRNA sponge regulates virus infection, cell cycle, and oncogenesis. Bioengineered 10:593\u2013603. https:\/\/doi.org\/10.1080\/21655979.2019.1679698","journal-title":"Bioengineered"},{"key":"1388_CR142","doi-asserted-by":"publisher","first-page":"11157","DOI":"10.1073\/pnas.1406136111","volume":"111","author":"J Qiu","year":"2014","unstructured":"Qiu J, Thorley-Lawson DA (2014) EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells. Proc Natl Acad Sci 111:11157\u201311162. https:\/\/doi.org\/10.1073\/pnas.1406136111","journal-title":"Proc Natl Acad Sci"},{"key":"1388_CR143","doi-asserted-by":"publisher","first-page":"e1002193","DOI":"10.1371\/journal.ppat.1002193","volume":"7","author":"J Qiu","year":"2011","unstructured":"Qiu J, Cosmopoulos K, Pegtel M, Hopmans E, Murray P, Middeldorp J, Shapiro M, Thorley-Lawson DA (2011) A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog 7:e1002193. https:\/\/doi.org\/10.1371\/journal.ppat.1002193","journal-title":"PLoS Pathog"},{"key":"1388_CR144","doi-asserted-by":"publisher","first-page":"e1004561","DOI":"10.1371\/journal.ppat.1004561","volume":"11","author":"J Qiu","year":"2015","unstructured":"Qiu J, Smith P, Leahy L, Thorley-Lawson DA (2015) The epstein-barr virus encoded BART miRNAs potentiate tumor growth in vivo. PLoS Pathog 11:e1004561. https:\/\/doi.org\/10.1371\/journal.ppat.1004561","journal-title":"PLoS Pathog"},{"key":"1388_CR145","doi-asserted-by":"publisher","first-page":"e27271","DOI":"10.1371\/journal.pone.0027271","volume":"6","author":"R Ramakrishnan","year":"2011","unstructured":"Ramakrishnan R, Donahue H, Garcia D, Tan J, Shimizu N, Rice AP, Ling PD (2011) Epstein-barr virus BART9 miRNA modulates LMP1 levels and affects growth rate of nasal NK T cell lymphomas. PLoS ONE 6:e27271. https:\/\/doi.org\/10.1371\/journal.pone.0027271","journal-title":"PLoS ONE"},{"key":"1388_CR146","doi-asserted-by":"publisher","first-page":"e1004906","DOI":"10.1371\/journal.ppat.1004906","volume":"11","author":"C Rancan","year":"2015","unstructured":"Rancan C, Schirrmann L, H\u00fcls C, Zeidler R, Moosmann A (2015) Latent membrane protein LMP2A impairs recognition of EBV-infected cells by CD8\u2009+\u2009T cells. PLoS Pathog 11:e1004906. https:\/\/doi.org\/10.1371\/journal.ppat.1004906","journal-title":"PLoS Pathog"},{"key":"1388_CR147","doi-asserted-by":"publisher","first-page":"6536","DOI":"10.1073\/pnas.1301620110","volume":"110","author":"AD Redfern","year":"2013","unstructured":"Redfern AD, Colley SM, Beveridge DJ, Ikeda N, Epis MR, Li X, Foulds CE, Stuart LM, Barker A, Russell VJ (2013) RNA-induced silencing complex (RISC) proteins PACT, TRBP, and Dicer are SRA binding nuclear receptor coregulators. Proc Natl Acad Sci 110:6536\u20136541. https:\/\/doi.org\/10.1073\/pnas.1301620110","journal-title":"Proc Natl Acad Sci"},{"key":"1388_CR148","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/978-3-319-22834-1_12","volume":"2","author":"ME Ressing","year":"2015","unstructured":"Ressing ME, van Gent M, Gram AM, Hooykaas MJ, Piersma SJ, Wiertz EJ (2015) Immune evasion by Epstein-Barr virus. Epstein barr virus 2: one herpes virus: many diseases. Springer 2:355\u2013381. https:\/\/doi.org\/10.1007\/978-3-319-22834-1_12","journal-title":"Springer"},{"key":"1388_CR149","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1038\/cddis.2012.18","volume":"3","author":"A Richard","year":"2012","unstructured":"Richard A, Tulasne D (2012) Caspase cleavage of viral proteins, another way for viruses to make the best of apoptosis. Cell Death Dis 3:e277\u2013e277. https:\/\/doi.org\/10.1038\/cddis.2012.18","journal-title":"Cell Death Dis"},{"key":"1388_CR150","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1038\/emboj.2012.63","volume":"31","author":"KJ Riley","year":"2012","unstructured":"Riley KJ, Rabinowitz GS, Yario TA, Luna JM, Darnell RB, Steitz JA (2012) EBV and human MicroRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J 31:2207\u20132221. https:\/\/doi.org\/10.1038\/emboj.2012.63","journal-title":"EMBO J"},{"key":"1388_CR151","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41584-024-01167-9","volume":"20","author":"WH Robinson","year":"2024","unstructured":"Robinson WH, Younis S, Love ZZ, Steinman L, Lanz TV (2024) Epstein\u2013Barr virus as a potentiator of autoimmune diseases. Nat Rev Rheumatol 20:729\u2013740. https:\/\/doi.org\/10.1038\/s41584-024-01167-9","journal-title":"Nat Rev Rheumatol"},{"key":"1388_CR152","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1596","volume":"14","author":"P Rommer","year":"2024","unstructured":"Rommer P, Puchhammer-St\u00f6ckl E, Lassmann H, Berger T, Vietzen H (2024) Ineffective control of Epstein-Barr virus infection is seen in MS: what is next? Clin Transl Med 14:e1596. https:\/\/doi.org\/10.1002\/ctm2.1596","journal-title":"Clin Transl Med"},{"key":"1388_CR153","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1038\/leu.2012.108","volume":"26","author":"P Rosato","year":"2012","unstructured":"Rosato P, Anastasiadou E, Garg N, Lenze D, Boccellato F, Vincenti S, Severa M, Coccia E, Bigi R, Cirone M (2012) Differential regulation of miR-21 and miR-146a by Epstein\u2013Barr virus-encoded EBNA2. Leukemia 26:2343\u20132352. https:\/\/doi.org\/10.1038\/leu.2012.108","journal-title":"Leukemia"},{"key":"1388_CR154","first-page":"210","volume":"3","author":"N Ross","year":"2013","unstructured":"Ross N, Gandhi MK, Nourse JP (2013) The Epstein-Barr virus MicroRNA BART11-5p targets the early B-cell transcription factor EBF1. Am J Blood Res 3:210\u2013224","journal-title":"Am J Blood Res"},{"key":"1388_CR155","doi-asserted-by":"publisher","first-page":"609","DOI":"10.5732\/cjc.014.10190","volume":"33","author":"M Rowe","year":"2014","unstructured":"Rowe M, Fitzsimmons L, Bell AI (2014) Epstein-Barr virus and Burkitt lymphoma. Chin J Cancer 33:609\u2013619. https:\/\/doi.org\/10.5732\/cjc.014.10190","journal-title":"Chin J Cancer"},{"key":"1388_CR156","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1093\/clinchem\/hvab052","volume":"67","author":"JM Ruijter","year":"2021","unstructured":"Ruijter JM, Barnewall RJ, Marsh IB, Szentirmay AN, Quinn JC, van Houdt R, Gunst QD, van den Hoff MJB (2021) Efficiency correction is required for accurate quantitative PCR analysis and reporting. Clin Chem 67:829\u2013842. https:\/\/doi.org\/10.1093\/clinchem\/hvab052","journal-title":"Clin Chem"},{"key":"1388_CR157","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00705-024-06080-w","volume":"169","author":"M Sabbaghian","year":"2024","unstructured":"Sabbaghian M, Gheitasi H, Fadaee M, Javadi Henafard H, Tavakoli A, Shekarchi AA, Poortahmasebi V (2024) Human cytomegalovirus micrornas: strategies for immune evasion and viral latency. Arch Virol 169:157. https:\/\/doi.org\/10.1007\/s00705-024-06080-w","journal-title":"Arch Virol"},{"key":"1388_CR158","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/BF00201464","volume":"13","author":"C Sample","year":"1991","unstructured":"Sample C, Kieff E (1991) Molecular basis for Epstein-Barr virus induced pathogenesis and disease. Springer Semin Immunopathol 13:133\u2013146. https:\/\/doi.org\/10.1007\/BF00201464","journal-title":"Springer Semin Immunopathol"},{"key":"1388_CR159","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/brain\/awae244","volume":"148","author":"T Schneider-Hohendorf","year":"2025","unstructured":"Schneider-Hohendorf T, W\u00fcnsch C, Falk S, Raposo C, Rubelt F, Mirebrahim H, Asgharian H, Schlecht U, Mattox D, Zhou W, Dawin E, Pawlitzki M, Lauks S, Jarius S, Wildemann B, Havla J, K\u00fcmpfel T, Schrot MC, Ringelstein M, Kraemer M, Schwake C, Schmitter T, Ayzenberg I, Fischer K, Meuth SG, Aktas O, H\u00fcmmert MW, Kretschmer JR, Trebst C, Kleffner I, Massey J, Muraro PA, Chen-Harris H, Gross CC, Klotz L, Wiendl H, Schwab N (2025) Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation. Brain 148:933\u2013940. https:\/\/doi.org\/10.1093\/brain\/awae244","journal-title":"Brain"},{"key":"1388_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2019.100641","volume":"34","author":"S Sharifipour","year":"2020","unstructured":"Sharifipour S, Rad KD (2020) Seroprevalence of Epstein\u2013Barr virus among children and adults in Tehran, Iran. New Microbes New Infect 34:100641. https:\/\/doi.org\/10.1016\/j.nmni.2019.100641","journal-title":"New Microbes New Infect"},{"key":"1388_CR161","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/978-981-97-4480-0_24","volume":"2","author":"B Sharma","year":"2024","unstructured":"Sharma B, Sharma U, Raina D, Sharma R, Singla M, Attri S (2024) Epstein\u2013Barr virus: emerging and re-emerging viral infectious diseases. Emerging human viral diseases, II: encephalitic, gastroenteric, and immunodeficiency viral infections. Springer 2:669\u2013691. https:\/\/doi.org\/10.1007\/978-981-97-4480-0_24","journal-title":"Springer"},{"key":"1388_CR162","doi-asserted-by":"publisher","first-page":"e2740","DOI":"10.1038\/cddis.2017.158","volume":"8","author":"J Shen","year":"2017","unstructured":"Shen J, Pan J, Du C, Si W, Yao M, Xu L, Zheng H, Xu M, Chen D, Wang S (2017) Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer. Cell Death Dis 8:e2740\u2013e2740. https:\/\/doi.org\/10.1038\/cddis.2017.158","journal-title":"Cell Death Dis"},{"key":"1388_CR163","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1182\/blood-2008-01-137018","volume":"112","author":"C Shi","year":"2008","unstructured":"Shi C, Sakuma M, Mooroka T, Liscoe A, Gao H, Croce KJ, Sharma A, Kaplan D, Greaves DR, Wang Y (2008) Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function. Blood 112:4699\u20134711","journal-title":"Blood"},{"key":"1388_CR164","doi-asserted-by":"publisher","first-page":"5581","DOI":"10.1128\/jvi.03639-14","volume":"89","author":"A Shinozaki-Ushiku","year":"2015","unstructured":"Shinozaki-Ushiku A, Kunita A, Isogai M, Hibiya T, Ushiku T, Takada K, Fukayama M (2015) Profiling of virus-encoded MicroRNAs in Epstein-Barr virus-associated gastric carcinoma and their roles in gastric carcinogenesis. J Virol 89:5581\u20135591. https:\/\/doi.org\/10.1128\/jvi.03639-14","journal-title":"J Virol"},{"key":"1388_CR165","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1297994","volume":"15","author":"JdM Silva","year":"2024","unstructured":"Silva JdM, Alves CEdC, Pontes GS (2024) Epstein-Barr virus: the mastermind of immune chaos. Front Immunol 15:1297994. https:\/\/doi.org\/10.3389\/fimmu.2024.1297994","journal-title":"Front Immunol"},{"key":"1388_CR166","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nri2691","volume":"10","author":"JE Sims","year":"2010","unstructured":"Sims JE, Smith DE (2010) The IL-1 family: regulators of immunity. Nat Rev Immunol 10:89\u2013102. https:\/\/doi.org\/10.1038\/nri2691","journal-title":"Nat Rev Immunol"},{"key":"1388_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2022.101272","volume":"56","author":"RL Skalsky","year":"2022","unstructured":"Skalsky RL (2022) MicroRNA-mediated control of Epstein\u2013Barr virus infection and potential diagnostic and therapeutic implications. Curr Opin Virol 56:101272. https:\/\/doi.org\/10.1016\/j.coviro.2022.101272","journal-title":"Curr Opin Virol"},{"key":"1388_CR168","doi-asserted-by":"publisher","first-page":"e1002484","DOI":"10.1371\/journal.ppat.1002484","volume":"8","author":"RL Skalsky","year":"2012","unstructured":"Skalsky RL, Corcoran DL, Gottwein E, Frank CL, Kang D, Hafner M, Nusbaum JD, Feederle R, Delecluse HJ, Luftig MA, Tuschl T, Ohler U, Cullen BR (2012) The viral and cellular MicroRNA targetome in lymphoblastoid cell lines. PLoS Pathog 8:e1002484. https:\/\/doi.org\/10.1371\/journal.ppat.1002484","journal-title":"PLoS Pathog"},{"key":"1388_CR169","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00530-00517","volume":"91","author":"CM Skinner","year":"2017","unstructured":"Skinner CM, Ivanov NS, Barr SA, Chen Y, Skalsky RL (2017) An Epstein-Barr virus microRNA blocks interleukin-1 (IL-1) signaling by targeting IL-1 receptor 1. J Virol 91:00517. https:\/\/doi.org\/10.1128\/jvi.00530-00517","journal-title":"J Virol"},{"key":"1388_CR170","doi-asserted-by":"publisher","first-page":"4212","DOI":"10.3390\/cancers16244212","volume":"16","author":"S Solares","year":"2024","unstructured":"Solares S, Le\u00f3n J, Garc\u00eda-Guti\u00e9rrez L (2024) The functional interaction between Epstein\u2013Barr virus and MYC in the pathogenesis of Burkitt lymphoma. Cancers 16:4212. https:\/\/doi.org\/10.3390\/cancers16244212","journal-title":"Cancers"},{"key":"1388_CR171","doi-asserted-by":"publisher","first-page":"36783","DOI":"10.18632\/oncotarget.9170","volume":"7","author":"Y Song","year":"2016","unstructured":"Song Y, Li X, Zeng Z, Li Q, Gong Z, Liao Q, Li X, Chen P, Xiang B, Zhang W (2016) Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1. Oncotarget 7:36783. https:\/\/doi.org\/10.18632\/oncotarget.9170","journal-title":"Oncotarget"},{"key":"1388_CR172","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042369","volume":"25","author":"IE Stergiou","year":"2024","unstructured":"Stergiou IE, Tsironis C, Papadakos SP, Tsitsilonis OE, Dimopoulos MA, Theocharis S (2024) Unraveling the role of the NLRP3 inflammasome in lymphoma: implications in pathogenesis and therapeutic strategies. Int J Mol Sci 25:2369. https:\/\/doi.org\/10.3390\/ijms25042369","journal-title":"Int J Mol Sci"},{"key":"1388_CR173","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.imlet.2012.04.007","volume":"146","author":"Y Sun","year":"2012","unstructured":"Sun Y, Cai J, Ma F, L\u00fc P, Huang H, Zhou J (2012) miR-155 mediates suppressive effect of progesterone on TLR3, TLR4-triggered immune response. Immunol Lett 146:25\u201330. https:\/\/doi.org\/10.1016\/j.imlet.2012.04.007","journal-title":"Immunol Lett"},{"key":"1388_CR174","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1146\/annurev.immunol.21.120601.140942","volume":"21","author":"SJ Szabo","year":"2003","unstructured":"Szabo SJ, Sullivan BM, Peng SL, Glimcher LH (2003) Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol 21:713\u2013758. https:\/\/doi.org\/10.1146\/annurev.immunol.21.120601.140942","journal-title":"Annu Rev Immunol"},{"key":"1388_CR175","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1084\/jem.20160248","volume":"213","author":"T Tagawa","year":"2016","unstructured":"Tagawa T, Albanese M, Bouvet M, Moosmann A, Mautner J, Heissmeyer V, Zielinski C, Lutter D, Hoser J, Hastreiter M, Hayes M, Sugden B, Hammerschmidt W (2016) Epstein-Barr viral miRNAs inhibit antiviral CD4\u2009+\u2009T cell responses targeting IL-12 and peptide processing. J Exp Med 213:2065\u20132080. https:\/\/doi.org\/10.1084\/jem.20160248","journal-title":"J Exp Med"},{"key":"1388_CR176","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14763","volume":"28","author":"T Tajima","year":"2024","unstructured":"Tajima T, Martinez OM, Bernstein D, Boyd SD, Gratzinger D, Lum G, Sasaki K, Tan B, Twist CJ, Weinberg K (2024) Epstein\u2013Barr virus-associated post\u2010transplant lymphoproliferative disorders in pediatric transplantation: a prospective multicenter study in the United States. Pediatr Transplant 28:e14763. https:\/\/doi.org\/10.1111\/petr.14763","journal-title":"Pediatr Transplant"},{"key":"1388_CR177","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1038\/s41598-017-02217-x","volume":"7","author":"SC Taylor","year":"2017","unstructured":"Taylor SC, Laperriere G, Germain H (2017) Droplet digital PCR versus qPCR for gene expression analysis with low abundant targets: from variable nonsense to publication quality data. Sci Rep 7:2409. https:\/\/doi.org\/10.1038\/s41598-017-02217-x","journal-title":"Sci Rep"},{"key":"1388_CR178","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.virol.2014.10.030","volume":"474","author":"RJ Tierney","year":"2015","unstructured":"Tierney RJ, Shannon-Lowe CD, Fitzsimmons L, Bell AI, Rowe M (2015) Unexpected patterns of Epstein\u2013Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA. Virology 474:117\u2013130. https:\/\/doi.org\/10.1016\/j.virol.2014.10.030","journal-title":"Virology"},{"key":"1388_CR179","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41571-024-00930-x","volume":"21","author":"K Toner","year":"2024","unstructured":"Toner K, McCann CD, Bollard CM (2024) Applications of cell therapy in the treatment of virus-associated cancers. Nat Rev Clin Oncol 21:709\u2013724. https:\/\/doi.org\/10.1038\/s41571-024-00930-x","journal-title":"Nat Rev Clin Oncol"},{"key":"1388_CR180","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3390\/cancers16050991","volume":"16","author":"AS Torne","year":"2024","unstructured":"Torne AS, Robertson ES (2024) Epigenetic mechanisms in latent Epstein-Barr virus infection and associated cancers. Cancers 16:991. https:\/\/doi.org\/10.3390\/cancers16050991","journal-title":"Cancers"},{"key":"1388_CR181","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.celrep.2013.09.012","volume":"5","author":"M-H Tsai","year":"2013","unstructured":"Tsai M-H, Raykova A, Klinke O, Bernhardt K, G\u00e4rtner K, Leung CS, Geletneky K, Sertel S, M\u00fcnz C, Feederle R (2013) Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas. Cell Rep 5:458\u2013470. https:\/\/doi.org\/10.1016\/j.celrep.2013.09.012","journal-title":"Cell Rep"},{"key":"1388_CR182","doi-asserted-by":"publisher","first-page":"1466339","DOI":"10.3389\/fimmu.2024.1466339","volume":"15","author":"A van de Waterweg Berends","year":"2024","unstructured":"van de Waterweg Berends A, Broux B, Machiels B, Gillet L, Hellings N (2024) The EBV-MS connection: the enigma remains. Front Immunol 15:1466339. https:\/\/doi.org\/10.3389\/fimmu.2024.1466339","journal-title":"Front Immunol"},{"key":"1388_CR183","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1111\/j.1600-6143.2009.02781.x","volume":"9","author":"M Vaysberg","year":"2009","unstructured":"Vaysberg M, Lambert SL, Krams SM, Martinez OM (2009) Activation of the JAK\/STAT pathway in epstein barr virus+-associated posttransplant lymphoproliferative disease: role of interferon-\u03b3. Am J Transplant 9:2292\u20132302. https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02781.x","journal-title":"Am J Transplant"},{"key":"1388_CR184","doi-asserted-by":"publisher","first-page":"11025","DOI":"10.1093\/nar\/gku826","volume":"42","author":"R Vento-Tormo","year":"2014","unstructured":"Vento-Tormo R, Rodr\u00edguez-Ubreva J, Lisio LD, Islam AB, Urquiza JM, Hernando H, Lopez-Bigas N, Shannon-Lowe C, Mart\u00ednez N, Montes-Moreno S (2014) NF-\u03baB directly mediates epigenetic deregulation of common MicroRNAs in Epstein-Barr virus-mediated transformation of B-cells and in lymphomas. Nucleic Acids Res 42:11025\u201311039. https:\/\/doi.org\/10.1093\/nar\/gku826","journal-title":"Nucleic Acids Res"},{"key":"1388_CR185","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/onc.2013.71","volume":"33","author":"DT Vereide","year":"2014","unstructured":"Vereide DT, Seto E, Chiu Y-F, Hayes M, Tagawa T, Grundhoff A, Hammerschmidt W, Sugden B (2014) Epstein\u2013Barr virus maintains lymphomas via its MiRNAs. Oncogene 33:1258\u20131264. https:\/\/doi.org\/10.1038\/onc.2013.71","journal-title":"Oncogene"},{"key":"1388_CR186","doi-asserted-by":"publisher","first-page":"6475","DOI":"10.1128\/jvi.00613-16","volume":"90","author":"JA Verhoeven Rob","year":"2016","unstructured":"Verhoeven Rob JA, Tong S, Zhang G, Zong J, Chen Y, Jin D-Y, Chen M-R, Pan J, Chen H (2016) NF-\u03baB signaling regulates expression of Epstein-Barr virus BART MicroRNAs and long noncoding RNAs in nasopharyngeal carcinoma. J Virol 90:6475\u20136488. https:\/\/doi.org\/10.1128\/jvi.00613-16","journal-title":"J Virol"},{"key":"1388_CR187","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61751-9","volume":"16","author":"H Vietzen","year":"2025","unstructured":"Vietzen H, K\u00fchner LM, Berger SM, Ponleitner M, Graninger M, Pistorius C, Jungbauer C, Reindl M, Saucke H, Kauth F, Wendel EM, Rost\u00e1sy K, Breu M, Kornek B, Bsteh G, Berger T, Rommer P, Puchhammer-St\u00f6ckl E (2025) Early identification of individuals at risk for multiple sclerosis by quantification of EBNA-1(381\u2013452)-specific antibody titers. Nat Commun 16:6416. https:\/\/doi.org\/10.1038\/s41467-025-61751-9","journal-title":"Nat Commun"},{"key":"1388_CR188","doi-asserted-by":"publisher","first-page":"e200460","DOI":"10.1212\/nxi.0000000000200460","volume":"12","author":"F Wahbeh","year":"2025","unstructured":"Wahbeh F, Sabatino JJ (2025) Epstein-Barr virus in multiple sclerosis: past, present, and future. Neurol Neuroimmunol Neuroinflamm 12:e200460. https:\/\/doi.org\/10.1212\/nxi.0000000000200460","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1388_CR189","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.3892\/or.2015.4237","volume":"34","author":"X-X Wan","year":"2015","unstructured":"Wan X-X, Yi H, Qu J-Q, He Q-Y, Xiao Z-Q (2015) Integrated analysis of the differential cellular and EBV MiRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues. Oncol Rep 34:2585\u20132601. https:\/\/doi.org\/10.3892\/or.2015.4237","journal-title":"Oncol Rep"},{"key":"1388_CR190","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4236\/ojped.2024.141012","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang Y, Chen P (2024) Research advances in infectious mononucleosis caused by Epstein-Barr virus. Open J Ped 14:108\u2013121","journal-title":"Open J Ped"},{"key":"1388_CR191","doi-asserted-by":"publisher","first-page":"565","DOI":"10.7150\/ijbs.24562","volume":"14","author":"M Wang","year":"2018","unstructured":"Wang M, Yu F, Wu W, Wang Y, Ding H, Qian L (2018) Epstein-Barr virus-encoded MicroRNAs as regulators in host immune responses. Int J Biol Sci 14:565. https:\/\/doi.org\/10.7150\/ijbs.24562","journal-title":"Int J Biol Sci"},{"key":"1388_CR192","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.omtn.2019.07.002","volume":"17","author":"M Wang","year":"2019","unstructured":"Wang M, Gu B, Chen X, Wang Y, Li P, Wang K (2019) The function and therapeutic potential of Epstein-Barr virus-encoded microRNAs in cancer. Molecular Therapy - Nucleic Acids 17:657\u2013668. https:\/\/doi.org\/10.1016\/j.omtn.2019.07.002","journal-title":"Molecular Therapy - Nucleic Acids"},{"key":"1388_CR193","doi-asserted-by":"publisher","first-page":"8012","DOI":"10.1096\/fj.202000039RR","volume":"34","author":"D Wang","year":"2020","unstructured":"Wang D, Zeng Z, Zhang S, Xiong F, He B, Wu Y, Li W, Tang L, Wei F, Xiang B (2020) Epstein-Barr virus\u2010encoded miR\u2010BART6\u20103p inhibits cancer cell proliferation through the LOC553103\u2010STMN1 axis. FASEB J 34:8012\u20138027. https:\/\/doi.org\/10.1096\/fj.202000039RR","journal-title":"FASEB J"},{"key":"1388_CR194","doi-asserted-by":"publisher","first-page":"198217","DOI":"10.1016\/j.virusres.2020.198217","volume":"291","author":"H Wang","year":"2021","unstructured":"Wang H, Liu W, Luo B (2021) The roles of MiRNAs and LncRNAs in Epstein-Barr virus associated epithelial cell tumors. Virus Res 291:198217. https:\/\/doi.org\/10.1016\/j.virusres.2020.198217","journal-title":"Virus Res"},{"key":"1388_CR195","doi-asserted-by":"publisher","first-page":"1505191","DOI":"10.3389\/fmicb.2024.1505191","volume":"15","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yu J, Pei Y (2024) Identifying the key regulators orchestrating Epstein-Barr virus reactivation. Front Microbiol 15:1505191. https:\/\/doi.org\/10.3389\/fmicb.2024.1505191","journal-title":"Front Microbiol"},{"key":"1388_CR196","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-4578-y","volume":"19","author":"JR Winter","year":"2019","unstructured":"Winter JR, Taylor GS, Thomas OG, Jackson C, Lewis JE, Stagg HR (2019) Predictors of Epstein-Barr virus serostatus in young people in England. BMC Infect Dis 19:1\u20139. https:\/\/doi.org\/10.1186\/s12879-019-4578-y","journal-title":"BMC Infect Dis"},{"issue":"9","key":"1388_CR197","doi-asserted-by":"publisher","first-page":"e1002902","DOI":"10.1371\/journal.ppat.1002902","volume":"8","author":"A Woellmer","year":"2012","unstructured":"Woellmer A, Arteaga-Salas JM, Hammerschmidt W (2012) BZLF1 governs CpG-Methylated chromatin of Epstein-Barr virus reversing epigenetic repression. PLoS Pathog 8(9):e1002902. https:\/\/doi.org\/10.1371\/journal.ppat.1002902","journal-title":"PLoS Pathog"},{"key":"1388_CR198","first-page":"372","volume":"91","author":"J Womack","year":"2015","unstructured":"Womack J, Jimenez M (2015) Common questions about infectious mononucleosis. Am Fam Physician 91:372\u2013376","journal-title":"Am Fam Physician"},{"key":"1388_CR199","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/cncr.26309","volume":"118","author":"AMG Wong","year":"2012","unstructured":"Wong AMG, Kong KL, Tsang JWH, Kwong DLW, Guan XY (2012) Profiling of Epstein-Barr virus\u2010encoded MicroRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Cancer 118:698\u2013710. https:\/\/doi.org\/10.1002\/cncr.26309","journal-title":"Cancer"},{"key":"1388_CR200","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.3892\/ol.2018.9041","volume":"16","author":"TS Wong","year":"2018","unstructured":"Wong TS, Chen S, Zhang MJ, Chan JY, Gao W (2018) Epstein-barr virus-encoded MicroRNA BART7 downregulates major histocompatibility complex class I chain-related peptide A and reduces the cytotoxicity of natural killer cells to nasopharyngeal carcinoma. Oncol Lett 16:2887\u20132892. https:\/\/doi.org\/10.3892\/ol.2018.9041","journal-title":"Oncol Lett"},{"key":"1388_CR201","doi-asserted-by":"publisher","unstructured":"Wong Y, Meehan MT, Burrows SR, Doolan DL, Miles JJ (2022) Estimating the global burden of Epstein\u2013Barr virus-related cancers. J Cancer Res Clin Oncol. https:\/\/doi.org\/10.1007\/s00432-021-03824-y","DOI":"10.1007\/s00432-021-03824-y"},{"key":"1388_CR202","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1158\/0008-5472.Can-07-5126","volume":"68","author":"T Xia","year":"2008","unstructured":"Xia T, O\u2019Hara A, Araujo I, Barreto J, Carvalho E, Sapucaia JB, Ramos JC, Luz E, Pedroso C, Manrique M (2008) EBV MicroRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res 68:1436\u20131442. https:\/\/doi.org\/10.1158\/0008-5472.Can-07-5126","journal-title":"Cancer Res"},{"key":"1388_CR203","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.7314\/APJCP.2013.14.10.5637","volume":"14","author":"Y-J Xie","year":"2013","unstructured":"Xie Y-J, Long Z-F, He X-S (2013) Involvement of EBV-encoded BART-miRNAs and dysregulated cellular MiRNAs in nasopharyngeal carcinoma genesis. Asian Pac J Cancer Prev 14:5637\u20135644. https:\/\/doi.org\/10.7314\/APJCP.2013.14.10.5637","journal-title":"Asian Pac J Cancer Prev"},{"key":"1388_CR204","doi-asserted-by":"publisher","first-page":"9967","DOI":"10.1128\/jvi.02244-06","volume":"81","author":"L Xing","year":"2007","unstructured":"Xing L, Kieff E (2007) Epstein-barr virus BHRF1 micro-and stable RNAs during latency III and after induction of replication. J Virol 81:9967\u20139975. https:\/\/doi.org\/10.1128\/jvi.02244-06","journal-title":"J Virol"},{"key":"1388_CR205","doi-asserted-by":"publisher","first-page":"e99857","DOI":"10.1371\/journal.pone.0099857","volume":"9","author":"G Xiong","year":"2014","unstructured":"Xiong G, Zhang B, Huang M-y, Zhou H, Chen L-z, Feng Q-s, Luo X, Lin H-j, Zeng Y-x (2014) Epstein-barr virus (EBV) infection in Chinese children: a retrospective study of age-specific prevalence. PLoS One 9:e99857. https:\/\/doi.org\/10.1371\/journal.pone.0099857","journal-title":"PLoS One"},{"key":"1388_CR206","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2023.100474","volume":"4","author":"M Xu","year":"2024","unstructured":"Xu M, Feng R, Liu Z, Zhou X, Chen Y, Cao Y, Valeri L, Li Z, Liu Z, Cao S-M (2024) Host genetic variants, Epstein-Barr virus subtypes, and the risk of nasopharyngeal carcinoma: assessment of interaction and mediation. Cell Genom 4:100474","journal-title":"Cell Genom"},{"key":"1388_CR207","doi-asserted-by":"publisher","first-page":"41766","DOI":"10.18632\/oncotarget.6155","volume":"6","author":"Q Yan","year":"2015","unstructured":"Yan Q, Zeng Z, Gong Z, Zhang W, Li X, He B, Song Y, Li Q, Zeng Y, Liao Q (2015) EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC. Oncotarget 6:41766. https:\/\/doi.org\/10.18632\/oncotarget.6155","journal-title":"Oncotarget"},{"key":"1388_CR208","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.molimm.2006.03.013","volume":"44","author":"Y Yang","year":"2007","unstructured":"Yang Y, Zhou H, Yang Y, Li W, Zhou M, Zeng Z, Xiong W, Wu M, Huang H, Zhou Y (2007) Lipopolysaccharide (LPS) regulates TLR4 signal transduction in nasopharynx epithelial cell line 5-8F via NF\u03baB and MAPKs signaling pathways. Mol Immunol 44:984\u2013992. https:\/\/doi.org\/10.1016\/j.molimm.2006.03.013","journal-title":"Mol Immunol"},{"key":"1388_CR209","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1007\/s13277-014-2938-1","volume":"36","author":"J-s Yang","year":"2015","unstructured":"Yang J-s, Li B-j, Lu H-w, Chen Y, Lu C, Zhu R-x, Liu S-h, Yi Q-t, Li J, Song C-h (2015) Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening. Tum Biol 36:3035\u20133042. https:\/\/doi.org\/10.1007\/s13277-014-2938-1","journal-title":"Tum Biol"},{"key":"1388_CR210","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2025.5494","volume":"55","author":"X-C Yao","year":"2025","unstructured":"Yao X-C, Wu J-J, Yuan S-T, Yuan F-L (2025) Recent insights and perspectives into the role of the miRNA\u201329 family in innate immunity. Int J Mol Med 55:1\u201312. https:\/\/doi.org\/10.3892\/ijmm.2025.5494","journal-title":"Int J Mol Med"},{"key":"1388_CR211","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bbrc.2013.05.008","volume":"436","author":"Y Ye","year":"2013","unstructured":"Ye Y, Zhou Y, Zhang L, Chen Y, Lyu X, Cai L, Lu Y, Deng Y, Wang J, Yao K (2013) EBV-miR-BART1 is involved in regulating metabolism-associated genes in nasopharyngeal carcinoma. Biochem Biophys Res Commun 436:19\u201324. https:\/\/doi.org\/10.1016\/j.bbrc.2013.05.008","journal-title":"Biochem Biophys Res Commun"},{"key":"1388_CR212","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-020-00848-8","volume":"13","author":"M Yi","year":"2020","unstructured":"Yi M, Xu L, Jiao Y, Luo S, Li A, Wu K (2020) The role of cancer-derived MicroRNAs in cancer immune escape. J Hematol Oncol 13:1\u201314. https:\/\/doi.org\/10.1186\/s13045-020-00848-8","journal-title":"J Hematol Oncol"},{"key":"1388_CR213","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s10120-020-01059-3","volume":"23","author":"CJ Yoon","year":"2020","unstructured":"Yoon CJ, Chang MS, Kim DH, Kim W, Koo BK, Yun S-C, Kim SH, Kim YS, Woo JH (2020) Epstein\u2013Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3\/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas. Gastric Cancer 23:780\u2013795. https:\/\/doi.org\/10.1007\/s10120-020-01059-3","journal-title":"Gastric Cancer"},{"key":"1388_CR214","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrc.2016.92","volume":"16","author":"LS Young","year":"2016","unstructured":"Young LS, Yap LF, Murray PG (2016) Epstein\u2013Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer 16:789\u2013802. https:\/\/doi.org\/10.1038\/nrc.2016.92","journal-title":"Nat Rev Cancer"},{"key":"1388_CR215","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3390\/v15030714","volume":"15","author":"H Yu","year":"2023","unstructured":"Yu H, Robertson ES (2023) Epstein\u2013barr virus history and pathogenesis. Viruses 15:714. https:\/\/doi.org\/10.3390\/v15030714","journal-title":"Viruses"},{"key":"1388_CR216","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/jcmm.13354","volume":"22","author":"J Zhang","year":"2018","unstructured":"Zhang J, Huang T, Zhou Y, Cheng AS, Yu J, To KF, Kang W (2018a) The oncogenic role of Epstein\u2013Barr virus-encoded micro RNA s in Epstein\u2013Barr virus\u2010associated gastric carcinoma. J Cell Mol Med 22:38\u201345. https:\/\/doi.org\/10.1111\/jcmm.13354","journal-title":"J Cell Mol Med"},{"key":"1388_CR217","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.virusres.2018.08.001","volume":"256","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Zhang W, Liu W, Liu H, Zhang Y, Luo B (2018b) Epstein\u2013Barr virus miRNA-BART16 modulates cell proliferation by targeting LMP1. Virus Res 256:38\u201344. https:\/\/doi.org\/10.1016\/j.virusres.2018.08.001","journal-title":"Virus Res"},{"key":"1388_CR218","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.4049\/jimmunol.2000341","volume":"205","author":"L Zhang","year":"2020","unstructured":"Zhang L, Chu Q, Chang R, Xu T (2020a) Inducible microRNA-217 inhibits NF-\u03baB\u2013and IRF3-driven immune responses in lower vertebrates through targeting TAK1. J Immunol 205:1620\u20131632. https:\/\/doi.org\/10.4049\/jimmunol.2000341","journal-title":"J Immunol"},{"key":"1388_CR219","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5217039","volume":"2020","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Luo D, Xie Z, He H, Duan Z (2020b) The oncogenic role of miR-BART19-3p in Epstein-Barr virus-associated diseases. BioMed Res Int 2020:5217039. https:\/\/doi.org\/10.1155\/2020\/5217039","journal-title":"BioMed Res Int"},{"key":"1388_CR220","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3390\/v15040832","volume":"15","author":"B Zhao","year":"2023","unstructured":"Zhao B (2023) Epstein\u2013Barr virus b cell growth transformation: nucear events. Viruses 15:832. https:\/\/doi.org\/10.3390\/v15040832","journal-title":"Viruses"},{"key":"1388_CR221","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1002\/jmv.24863","volume":"89","author":"Z Zhao","year":"2017","unstructured":"Zhao Z, Liu W, Liu J, Wang J, Luo B (2017) The effect of EBV on WIF1, NLK, and APC gene methylation and expression in gastric carcinoma and nasopharyngeal cancer. J Med Virol 89:1844\u20131851. https:\/\/doi.org\/10.1002\/jmv.24863","journal-title":"J Med Virol"},{"key":"1388_CR222","doi-asserted-by":"publisher","first-page":"4972","DOI":"10.18632\/oncotarget.6649","volume":"7","author":"XH Zheng","year":"2016","unstructured":"Zheng XH, Lu LX, Cui C, Chen MY, Li XZ, Jia WH (2016) Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma. Oncotarget 7:4972\u20134980. https:\/\/doi.org\/10.18632\/oncotarget.6649","journal-title":"Oncotarget"},{"key":"1388_CR223","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.897306","volume":"22","author":"L Zhou","year":"2016","unstructured":"Zhou L, Bu Y, Liang Y, Zhang F, Zhang H, Li S (2016) Epstein-Barr virus (EBV)-BamHI-A rightward transcript (BART)-6 and cellular microRNA-142 synergistically compromise immune defense of host cells in EBV-positive burkitt lymphoma. Med Sci Monit 22:4114. https:\/\/doi.org\/10.12659\/MSM.897306","journal-title":"Med Sci Monit"},{"key":"1388_CR224","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/pathogens9050353","volume":"9","author":"S \u017didovec Lepej","year":"2020","unstructured":"\u017didovec Lepej S, Matuli\u0107 M, Gr\u0161kovi\u0107 P, Pavlica M, Radmani\u0107 L, Kora\u0107 P (2020) MiRNAs: EBV mechanism for escaping host\u2019s immune response and supporting tumorigenesis. Pathogens 9:353. https:\/\/doi.org\/10.3390\/pathogens9050353","journal-title":"Pathogens"},{"key":"1388_CR225","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s12250-017-3996-5","volume":"32","author":"L Zuo","year":"2017","unstructured":"Zuo L, Yue W, Du S, Xin S, Zhang J, Liu L, Li G, Lu J (2017) An update: Epstein-Barr virus and immune evasion via MicroRNA regulation. Virol Sin 32:175\u2013187. https:\/\/doi.org\/10.1007\/s12250-017-3996-5","journal-title":"Virol Sin"},{"key":"1388_CR226","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.omtn.2019.05.023","volume":"17","author":"L Zuo","year":"2019","unstructured":"Zuo L, Xie Y, Tang J, Xin S, Liu L, Zhang S, Yan Q, Zhu F, Lu J (2019) Targeting exosomal EBV-LMP1 transfer and miR-203 expression via the NF-\u03baB pathway: the therapeutic role of aspirin in NPC. Mol Ther Nucleic Acids 17:175\u2013184. https:\/\/doi.org\/10.1016\/j.omtn.2019.05.023","journal-title":"Mol Ther Nucleic Acids"}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-025-01388-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12223-025-01388-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-025-01388-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:22:09Z","timestamp":1778574129000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12223-025-01388-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":226,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1388"],"URL":"https:\/\/doi.org\/10.1007\/s12223-025-01388-9","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"value":"0015-5632","type":"print"},{"value":"1874-9356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No animals or human subjects were used in the preparation of this review article. All datasets analyzed are publicly available and anonymized.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}